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ABSTRACT 
 The mammalian cell nucleus is a complex yet highly organized structure. There is 
significant amount of knowledge about the organization of nucleus; however, the 
influence of such structural complexity of the nucleus in gene regulation is poorly 
understood. For better understanding of the effects of nuclear repositioning of a gene 
locus on gene expression, I investigated the physiological significance and mechanism of 
association of a gene locus with a nuclear sub-compartment. In chapter 1, I showed an 
actin dependent association of HSP70 transgenes with nuclear speckles after heat shock. I 
visualized HSP70 transgenes moving curvilinearly towards nuclear speckles over ~0.5-6 
µm distances at velocities of 1-2 µm min-1. Observation of chromatin stretching in the 
direction of movement demonstrated a force generating mechanism. Transcription in 
nearly all cases increased noticeably only after initial contact with a nuclear speckle. The 
time lag between initial speckle contact and increased transcription was inversely 
proportional to the speckle size at first contact with the HSP70 transgene and after initial 
contact with small speckles an increase in speckle size typically preceded increased 
transcription. Our results demonstrate the existence of a still to be revealed machinery for 
moving chromatin in a direct path over long distances towards nuclear speckles in 
response to transcriptional activation.  
In Chapter 2, we used autonomous targeting of BAC transgenes to reveal cis 
requirements for peripheral targeting.  Three peripheral targeting regions (PTRs), 
including the 6 kb PTR1, target the ~100 kb beta-globin gene cluster and LCR region to 
the nuclear periphery and confer increased H3K9me3 modification, as assayed both by 
immunofluorescence and chromatin immunoprecipitation.  PTRs within HBB BACs bias 
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a competition between peripheral versus pericentric heterochromatin (PCH) targeting 
towards peripheral targeting.  Targeting to both heterochromatin compartments is 
dependent on H3K9 trimethylation.  More generally, PTRs confer targeting from the 
PCH to the periphery, from the interior to the PCH, or have no targeting activity 
depending on the flanking DNA context, with peripheral targeting correlating with 
higher, domain-wide H3K9m3 levels. A combination of FISH, BAC transgenesis, and 
knockdown experiments reveals that peripheral tethering of the endogenous HBB locus 
depends both on Suv39H-mediated H3K9me3 methylation over several hundred 
kilobases surrounding HBB and on G9a-mediated H3K9me2 methylation over flanking 
sequences in an adjacent Lamin Associated Domain.  Our results demonstrate multiple 
cis elements regulate the overall balance of specific epigenetic marks and peripheral gene 
targeting. 
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 1 
CHAPTER 1 
 
Introduction 
The chromatin in the nucleus is arranged in a highly ordered manner (1,2). It is 
compartmentalized into chromosome territories as well as many distinct nuclear bodies 
such as speckles, paraspeckles, nucleoli, Cajal bodies, polycomb bodies, and 
promyelocytic leukemia bodies (3,4). Multiple lines of evidence have suggested that the 
association of genes with nuclear bodies or sub-compartments may play a critical role in 
gene regulation (5-6). Beta-globin and immunoglobulin heavy chain (IgH) loci are 
located at the nuclear periphery when they are inactive (7,8).  Upon gene activation 
during development, these genes relocate to an interior position in the nucleus. In mouse 
B-lymphocytes, the Myc gene, upon transcriptional activation preferentially moved to the 
transcription factories preoccupied by the Igh gene, which is located on a different 
chromosome (9). These and several other investigations strongly suggest a link between 
the nuclear positioning of a gene and its gene regulation (10,11). 
Although, the association of gene loci with specific nuclear bodies has been 
proposed to play a critical role in gene regulation, neither the mechanism nor the 
functional significance of this association is known. In an attempt to address these 
questions, the studies in this dissertation used two experimental systems. First, utilizing 
the targeting of HSP70 transgenes to nuclear speckle, we investigated how HSP70 
transgenes become associated with nuclear speckle and determined the temporal 
relationship between association of HSP70 transgenes and nuclear speckles. Second, 
using the targeting of HBB transgenes to nuclear periphery, we determined the cis-
requirements for peripheral targeting of HBB gene locus.   
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Technology to Visualize Chromatin in Live Cells: 
Earlier it was not possible to follow the changes in nuclear position of a gene 
locus in live cells. Belmont laboratory first engineered an in vivo tagging system to 
visualize specific chromatin regions (12,13). By expressing eGFP-dlacI fusion protein in 
living cells, the chromosome regions tagged with LacO repeats could be visualized and 
followed over time. In a previous study, a transgene array tagged with LacO repeats was 
observed to move from the nuclear periphery to the nuclear interior after tethering a 
transcriptional activator to the array (14).  Live-cell imaging demonstrated unidirectional 
long-range movement along a curvilinear path (15).  
Whereas the Belmont laboratory provided the first example of long-range 
chromatin motion that appeared to be active, there were limitations with the previous 
experimental system: a) It was an artificial system with no physiological connection; b) it 
was known that the spot was moving away from the periphery but unknown whether it 
was moving to a particular nuclear region; c) motions were typically just 1-2 microns 
over several minutes and some of these could have been possibly coupled to the nuclear 
shape changes. So, a clear demonstration of the long-range motion was missing; d) there 
was no clear experimental system to analyze the functional consequence of motion, i.e. 
its relationship to transcriptional activation and output. 
In this thesis project, we used the fast responding heat shock gene to examine the 
chromatin motion within the nucleus and the effect of association of the HSP70 
transgenes with nuclear speckles on transcription. 
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Nuclear Speckles and Gene Expression: 
Nuclear speckles or Interchromatin Granule Clusters (IGC) (16) or SC35 domains 
(17) are one of the most universal and abundant nuclear bodies (18). Nuclear speckles are 
dynamic structures with varying size, shape and number among different cell types 
(19,20). They are highly enriched in RNA processing factors including snRNP, SR 
proteins, kinases, phosphatases, small RNAs that are involved in transcription, pre-
mRNA splicing and nuclear export (21-25). Nuclear speckles were one of the first 
described nuclear sub-structures, yet their exact functional role is poorly understood.  
Various models suggest that speckles are reservoirs for factors involved in RNA 
processing (24,27). For instance, inhibition of RNA Polymerase II transcription reduces 
the recruitment of splicing factors to the sites of transcription and causes speckles to 
become larger and rounded (19,28). Nucleotide incorporation and immunocytochemistry 
studies have also shown that the interior of nuclear speckles is not likely the site of 
transcription (29,30).  
On the other hand, there is a significant amount of research suggesting that the 
nuclear speckles are not just the simple storage sites of inert splicing factors, but are 
instead actively involved in transcription, along with other nuclear functions (26). For 
example, disassembly of nuclear speckles caused by overexpression of SR protein kinase 
does not affect overall transcription but disrupts the coordination between transcription 
and pre-mRNA splicing in mammalian cell nuclei, suggesting a role of the nuclear 
speckle structure in transcription-splicing coupling (24).  
Gene rich chromosomal Reverse-bands (R-band) preferentially align with SC-35 
domains as compared to the gene poor Giemsa bands (G-band) (31). These aligned R-
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bands contain active genes that cluster at the edge of the nuclear speckle. More 
specifically, it was shown that transcriptionally active genes preferentially associate with 
nuclear speckles. Of the 21 active genes tested, 10 show localization at the edge of 
nuclear speckles (32,33). The active allele of Glial Fibrillary Acidic Protein (GFAP) 
frequently associates with nuclear speckles, whereas the inactive GFAP doesn’t associate 
with nuclear speckles (34). Co-expressed erythroid genes are also shown to cluster 
around nuclear speckles (35) leading to a model in which nuclear speckle domains 
organize hubs of local euchromatin neighborhoods (31,36).  
There is evidence of nuclear speckles possibly being involved in mRNA 
processing. Normal DMPK (dystrophia myotonica protein kinase) transcripts enter 
nuclear speckles and are then exported out of them, whereas the mutant DMPK mRNA 
fails to enter SC35 speckles and instead accumulates in a granule structure nearby nuclear 
speckle (37,38). A mutant Collagen 1a1 mRNA enters into nuclear speckles but fails to 
exit, whereas its corresponding normal transcript exits the nuclear speckles and is 
exported to the cytoplasm (38). These and some other observations suggest that pre-
mRNA transcripts can be retained within nuclear speckles (39), to acquire the ability to 
get exported (40,41).  
The non-coding RNAs (nc-RNA) within nuclear speckles play a major role in 
gene regulation (42,43). Recently, it was shown that in response to growth signals, nc-
RNA along with chromatin binding protein, Polycomb 2, controls the relocation of 
growth control genes from transcriptionally repressive polycomb bodies to 
transcriptionally permissive nuclear speckles (44). 
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The mammalian genes that are associated with nuclear speckles are broadly 
classified into two distinct categories (37); Class I genes in which transcript accumulates 
within the speckle interior and Class II genes where transcripts remain outside of nuclear 
speckles.  Previous work in the Belmont laboratory showed that HSP70 transgenes after 
induction with heat shock behave like Class I genes, similar to the behavior of the 
endogenous HSP70 locus (39,45,46). This association of HSP70 transgenes and their 
transcripts with nuclear speckles is dependent on the HSP70 promoter and transcription.  
To observe the in vivo dynamics between the transgene and nuclear speckles, 
stable cell lines that co-expressed Lac operator tagged HSP70 transgenes and mRFP-
SFRS1 (marker for nuclear speckles, previously known as ASF/SF2) (45) were 
generated. Initial live-cell imaging performed by former laboratory member Yan Hu, 
suggested three possible pathways for speckle association (45): a) Long-range movement 
of HSP70 transgenes towards a pre-existing nuclear speckle; b) Enlargement of the 
nearby nuclear speckle and wrapping of BAC HSP70 transgenes around it; c) Nucleation 
of new nuclear speckles near the HSP70 transgene. 
This earlier study in Belmont laboratory was limited due to certain technical 
challenges; a) The mRFP-SRSF1 nuclear speckle marker used in the previous 
experimental system had low contrast between the labeled nuclear speckles and 
nucleoplasmic background. This required high light dosages to resolve nuclear speckles 
from the nuclear background. In addition, there was always a possibility of overlooking 
the presence of small nuclear speckles buried in the background; b) the microscope 
system required high exposure levels and had slow 3D image acquisition; c) there was no 
ability to track transcripts in live cells during the nuclear speckle association process. 
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The work done in Chapter 2 utilizes a much-improved experimental system to 
determine how HSP70 transgenes associate with nuclear speckles, along with 
investigating the very challenging question of the effect of changes in HSP70 gene 
association with nuclear speckles on the transcription of these HSP70 genes.  
 
Nuclear Lamina and Gene Repression: 
The nuclear lamina is a filamentous network that underlines the inner nuclear 
membrane. In mammalian cells, the nuclear lamina consists of B-type lamins (Lamin B1 
and B2); and A-type lamins (Lamin A and C).  In most cell types, the B-type lamins are 
located at the nuclear lamina, while A-type lamins are also present in the nucleoplasm. 
The role of nucleoplasmic lamin is unclear (47-49). The mutation in genes coding for 
lamins causes laminopathies, including Progeria, muscular dystrophy, and restrictive 
dermopathy (50). 
Genome-wide studies using the DamID method have mapped preferred genome-
lamina interactions (51).  In mammalian genome, more than 1100-1400 sharply defined 
domains, called Lamina Associated Domains (LADs), size ranging in of 10kb to 10Mb 
were shown to preferentially interact with the nuclear lamina (51). Most from genes 
within LADs are transcriptionally inactive and contain histone marks associated with 
some repression. 
Several developmentally regulated genes are at the nuclear periphery in their 
inactive state but reposition to the nuclear interior upon gene activation, suggesting that 
peripheral gene localization may help establish and/or maintain developmental gene 
repression. Similarly, some inactive genes localize to peri-centromeric heterochromatin 
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(PCH).  In cycling primary B lymphocytes or developing T cells, PCH association 
correlated with heritable gene silencing (52-57). In mammalian cells, recruitment of gene 
loci to nuclear periphery (58-60) have suggested that gene repression associated with 
tethering was promoter specific and quantitative, dampening transcription rather than 
completely turning it off. Little is known about how endogenous gene loci are targeted to 
the nuclear periphery (61-63). In Chapter 3, using a heavily studied developmentally 
regulated genomic loci beta-globin, we dissected the cis requirements for peripheral 
targeting. 
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CHAPTER 2 
HSP70 Transgene Directed Motion to Nuclear Speckles Facilitates  
Heat Shock Activation1 
 
Summary: 
 
 Association and disassociation of gene loci with respect to specific nuclear 
compartments accompany changes in gene expression, yet little is known concerning the 
mechanisms by which this occurs or its functional consequences.  Previously we showed 
that tethering acidic activators to a peripheral chromosome site led to movement of the 
chromosome site away from the nuclear periphery, but the physiological relevance of this 
movement was unclear (1).  Nuclear speckles, or interchromatin granule clusters, are 
enriched in factors involved in RNA processing (2), and the association of a subset of 
active genes at their periphery suggests speckles may play a role in gene expression (3,4).  
Here we show an actin dependent association of HSP70 transgenes with nuclear speckles 
after heat shock.  We visualized HSP70 transgenes moving curvilinearly towards nuclear 
speckles over ~0.5-6 µm distances at velocities of 1-2 µm min-1.  Chromatin stretching in 
the direction of movement demonstrates a force generating mechanism. Transcription in 
nearly all cases increased noticeably only after initial contact with a nuclear speckle. 
Moreover, blocking new HSP70 transgene / speckle association by actin 
                                                
1 This chapter appeared in its entirety in Current Biology. Nimish Khanna, Yan Hu, 
Andrew S. Belmont (2014) HSP70 transgene directed motion to nuclear speckles 
facilitates heat shock activation. Current Biology 19;24(10):1138-44. doi: 
10.1016/j.cub.2014.03.053. Epub 2014 May 1. PMID: 24794297 
 
Author Contributions: Y. H. constructed the HSP70 plasmid with the 5’ UTR MS2 
repeat insert and created the C42 cell line. N. K. carried out all other experimental 
work. N.K. and A.S.B. designed the experiments and analyzed the results. A.S.B. 
supervised the study and together with N.K. wrote the paper. 	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depolymerization prevented significant heat-shock induced transcriptional activation in 
transgenes not associated with speckles, although robust transcriptional activation was 
observed for HSP70 transgenes associated with nuclear speckles.  Our results 
demonstrate the existence of a still to be revealed machinery for moving chromatin in a 
direct path over long distances towards nuclear speckles in response to transcriptional 
activation; moreover this speckle association enhances the heat-shock activation of these 
HSP70 transgenes.   
 
Results and Discussion: 
 HSP70 transgenes associate with nuclear speckles (5.6), recapitulating the heat 
shock dependent speckle association of the endogenous locus (7).  Consistent with 
previous demonstrations of speckle association for only ~50% of 25 active genes 
surveyed (3,4), no speckle association of MT (metallothionein) or DHFR transgenes was 
observed after their transcriptional activation (5,6).  Moreover, neither MT nor DHFR 
transgenes associated with nuclear speckles after heat shock (data not shown).  Promoter 
swapping experiments showed that HSP70 speckle association was conferred specifically 
by the HSP70 upstream regulatory region (6).  HSP70 transgene speckle association was 
specific to heat shock, as transcriptional activation by cadmium did not result in speckle 
association (6). 
 Our previous work indicated that speckle association occurred mostly through 
apparent de novo formation of a nuclear speckle or association with a nearby, pre-
existing speckle (5).  Hints of long-range movements of the transgenes to nuclear 
speckles were limited by technical factors.  In particular, long-range chromosome 
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movements are profoundly sensitive to phototoxicity, yet our previous live-cell imaging  
(5) used light levels shown to inhibit long-range movements (1). In most cells the BAC 
transgene array localized near a pre-existing nuclear speckle even before heat shock 
activation, but we were limited to live cell microscopy of 1-2 cells per experiment, 
reducing the number of observations for statistical analysis.  Our speckle marker showed 
a poor speckle to nuclear background ratio, making it difficult to detect small speckles.  
Finally, we had no direct, live-cell readout of transcriptional activity, complicating efforts 
to relate changes in transgene nuclear position to changes in transcriptional activity. 
 Here, an Applied Precision OMX microscope provided reduced phototoxicity and 
increased data acquisition speeds.  A plasmid containing a 64-mer lac operator repeat, 
selectable marker, and the HSPA1A gene (6) was modified to insert 24 MS2 repeats into 
the HSPA1A 5' UTR and stably transfected into CHO DG44 cells expressing EGFP-LacI 
(Fig. 2.1A,C).  Expressing EGFP-SON from a BAC transgene, recombineered to insert 
the EGFP in frame into the SON NH2 terminus, provided uniform expression and 
visualization of nuclear speckles (Fig. 2.1B-C).  Uniform EGFP-SON expression allowed 
us to simultaneously localize the higher intensity EGFP tagged HSP70 transgenes relative 
to the lower intensity EGFP labeled nuclear speckles in stably transfected cell clones 
(Fig. 2.1C-F).  A second transfection yielded cells stably expressing MS2 binding 
protein- mCherry for labeling of nascent transcripts (Fig. 2.1C).  
 Nuclear speckle location is biased towards the nuclear interior [8].  Using cell 
clone C16_C4_1 in which the HSP70 plasmid transgene array is preferentially positioned 
at the nuclear periphery (Fig. 2.1D), we increased the fraction of cells in which the array 
is not close to any speckle prior to heat shock.  For this cell clone, containing ~700 
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plasmid copies as estimated by qPCR, the 25% to 71% increased array association with 
nuclear speckles (Fig. 2.1E-G) and HSP70 transcript accumulation within nuclear 
speckles after heat shock (data not shown) were similar to that previously observed for 
plasmid HSP70 transgenes (6). In previous work where active interphase chromosomal 
motion was suspected, an either direct or indirect dependence on actin was implicated 
through dominant negative and/or inhibitor studies (1,9,10).  Similarly, speckle 
association of the HSP70 transgene array after heat shock was blocked by expression of a 
nonpolymerizable NLS-RFP-actin G13R mutant, incapable of actin polymerization, but 
not by expression of the corresponding wild type actin construct (Fig. 2.1H).  Because 
these actin fusion proteins are concentrated in the nucleus, a dependence specifically on 
nuclear actin is suggested.  HSP70 transgene association with nuclear speckles was also 
blocked by treatment with latrunculin A, which depolymerizes F-actin, and by 
jasplakinolide, which blocks F-actin depolymerization (Fig. 2.1H). 
 Directed chromosome motion is difficult to distinguish from the rapid, 
"constrained diffusion" motion (11) observed at most chromosome loci in a wide range of 
eukaryotic cells, including mammalian (12).  We focused on movements at least two-fold 
longer-range than the ~ 0.2 µm "radius of constraint" derived from mean square 
displacement (MSD) versus time measurements at both 37 and 44o C (Fig. A.1).  We 
collected 3D images every 2 min for 60 min for ~900 cells (~400 movies) identifying 90 
cells in which the starting distance between the transgene array and the nearest nuclear 
speckle was at least 0.4 µm.  Inspection of 2D projections versus time revealed long-
range movements exceeding 0.4 µm in ~50% of these 90 cells.  Nearly all of these 
movements terminated at a nuclear speckle (Fig. 2.2A), although in several cases the 
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transgene array moved to one speckle and then to another.  (Speckle-transgene 
association in ~20% of these 90 cells occurred through de novo formation or enlargement 
of a speckle, as previously described (5), or, in ~10% of these cells, through speckle 
protrusion or motion.  Otherwise, either no speckle association was observed or 
association occurred through a complex combination of events.) 
 Long-range movements, typically over 2-4 min, ranged from 0.5 to 6 µm (median 
1.7 µm) (Video E1).  We created a derivative cell line stably expressing CENPA-
mCherry together with EGFP-SON and EGFP-LacI.  The CENPA-mCherry labeled 
centromeres served as 3D fiducial marks, demonstrating that transgene movements were 
not due to nuclear rotation (Fig. 2.2B-C, Video E2).  Similar long-range movements were 
not observed at 37o or at 44o C in cells carrying lac operator / repressor tagged, MT BAC 
transgene arrays.  In cells showing long-range movement,  ~20% of Δd values, measuring 
the change in position during a single, 2 min time interval, exceeded the maximum Δd 
value observed in cells at 37o C or, after heat shock, in CHO DG44 cells containing a 
control metallothionein BAC transgene array (cell clone MT1_1_4, reference (5)) (Fig. 
2.S1B-D).  No examples of long-range movements to nuclear speckles or long-range 
movements per se after heat shock were observed in movies of ~200 cells carrying the 
control, MT BAC transgene array (data not shown) or in ~350 cells at 37o C carrying the 
HSP70 plasmid transgene array. 
 Linear trajectories of transgenes directed towards nuclear speckles were revealed 
using shorter 30 sec time intervals (Fig. 2.2C-H, Video E3); the mean velocity measured 
in these trajectories during motion was 1.14 µm min-1.  Linearity was indicated by both 
the absolute angular offset between consecutive steps (14.2° mean, 15.7° sd, Fig. 2.
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and by the ratio between the sum of all vector step lengths and the net vector length 
(1.094 mean, 0.147 sd, Fig. 2.2K) for 10 trajectory examples.  Directionality towards 
nuclear speckles was supported by two measures.  First, we measured the magnitude of 
the angular deviation of each step direction from the vector defined by the line 
connecting the starting transgene position and its end position adjacent to the nuclear 
speckle (7.9o mean, 29.1o max, 7.3o sd).  Trajectories varied from 2-10 steps (4.2 mean).  
Assuming all directions are equally likely, the probability in a random walk for all 4 steps 
deviating less than or equal to the ~30° observed maximum from the speckle direction is  
~0.0008 ((30/180)4) and becomes vanishingly smaller with angular deviations closer to 
the mean.  Second, we measured the sum of all angles represented by possible trajectories 
that would intercept a speckle based on the geometry observed at the first time point in 
the trajectory (139o mean, 33.1o sd).  The probability of all 10 long-range trajectories 
terminating at a speckle over the 360o possible directions for each would be ~0.00007 
((139/360)10).  These numbers strongly support directed movement towards speckles 
rather than a “speckle capture” model in which trajectories end when they hit a speckle. 
 Transient chromatin stretching in the trajectory direction demonstrates a force-
generating mechanism underlying these long-range movements and further supports their 
directionality.  Approximately 40% of long-range movements (18/46) were accompanied 
by chromatin stretching during and sometimes immediately preceding movement, while 
relaxation of stretching was typically observed after the movement stopped (Fig. 2.3A-D, 
Video E4). The angle between the estimated directions of stretching versus movement 
averaged 3.5 o (7.6o sd) for 14 examples (Fig. 2.3E).  No examples of stretching were 
observed in 350 cells at 37o C or 200 cells carrying metallothionine gene arrays at 44o C.  
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In 3/90 cells, dramatic chromatin stretching occurred without actual movement to a 
speckle (Video E5). 
 Stretching, rather than re-orientation of a fiber segment from parallel to 
perpendicular to the optical axis, was inferred from inspection of optical sections and 
seeing a round spot change to an elliptical or linear shape.  Limited resolution along the 
optical axis complicates unambiguous discrimination between stretching versus re-
orientation for structures ≤ ~0.5 µm in length.  However, stretching rather than re-
orientation is clearly established by multiple examples in which distinct and sufficiently 
large deformations occur perpendicular to the optical axis (Fig. 2.3C).   
 All of the preceding experiments were done using a high copy number plasmid 
transgene array, raising questions of whether similar long-range motion would be 
observed with a low copy number HSP70 BAC transgene array, which more closely 
approximates the behavior of the endogenous locus (5,6).  We deliberately used a HSP70 
BAC in which two of the three HSP70 genes contained at this locus were deleted (6) 
(Fig. A.2).   We also used a CHO cell clone containing only  ~1-3 copies (as measured by 
qPCR) of this HSP70 BAC; therefore the total number of HSP70 genes approximates that 
of the endogenous locus.  Unfortunately, in this clone nearly all cells showed the BAC 
transgene array prior to heat shock already too close to a nuclear speckle to distinguish 
subsequent motions to these nearby speckles as either directed or resulting from 
“constrained diffusion”.  Significantly, however, we were able to capture several 
examples of similar long-range trajectories towards nuclear speckles using this low-copy 
HSP70 BAC transgene (Fig. A.2B-D).   
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 In fixed cells we observed a strong positive correlation between the nascent RNA 
(either MS2 or FISH) signal at the plasmid transgene array and speckle size (data not 
shown).  In several cases in which the HSP70 plasmid transgene array was split into 
spatially distinct spots, only the spot in contact with a nuclear speckle showed a 
measurable nascent RNA signal (Fig. 2.1C).  Stable expression of the MS2-binding 
protein in these cells perturbs nascent transcript processing.  Specifically, without 
expression of the MS2-binding protein, RNA FISH demonstrates transcript accumulation 
within the speckle (data not shown) as previously observed (5,6). With expression of the 
MS2-binding protein, HSP70 transcripts accumulate adjacent to rather than inside nuclear 
speckles (Fig. 2.1C) and appear to progressively accumulate over time as if release from 
the transgene array is inhibited (Fig. 2.4A-B).  The timing of transcriptional induction, 
however, parallels what we observe by RNA FISH in cells not expressing the MS2 
binding protein.  MS2- mCherry signals therefore likely reflect the integrated 
transcription amount over time, but as a consequence provide a sensitive assay for 
transcriptional output.  
 A priori, this correlation between speckle size and nascent RNA signal at the 
associated HSP70 plasmid transgene array is consistent with either facilitated HSP70 
transgene transcription through association with a nuclear speckle and/or with HSP70 
transgene transcription causing an increase in the size of associated nuclear speckles.   
 We addressed the causal relationship between transcription and speckle 
association by using live cell microscopy to determine the temporal relationship between 
HSP70 plasmid transgene transcription and speckle association.  In these experiments we 
counted all examples in which the transgene array initially shows no speckle association.  
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Live cell microscopy revealed that in 31/32 movements of HSP70 transgene arrays to 
nuclear speckles, the MS2 binding protein- mCherry signal first increased above the 
nucleoplasmic background only after initial contact of the transgene array with a nuclear 
speckle (Fig. 2.4A-B, Video E6).  As previously noted, occasionally the transgene array 
makes transient contact, comes off, and then reattaches to the same (Fig. 2.4A, Video E6) 
or even a different speckle.  Therefore we cannot exclude the possibility that in the one 
example in which transcription begins prior to nuclear speckle association that a transient 
speckle association occurred between adjacent time points. 
 Plotting speckle size versus integrated MS2-binding protein signal as a function 
of time after first contact showed a range of patterns.  However, a general trend was 
suggested in which when transgenes contacted a small speckle, a jump in speckle size 
preceded the onset of significant transgene transcript accumulation (Fig. 2.4C); in 
contrast, when transgene arrays contacted larger speckles there was a more immediate 
rise in transcript accumulation (Fig. 2.4D).  Plotting speckle size and transcript levels 
averaged over all cells for each time revealed the average trend in which initially speckle 
size increases more rapidly than transcript followed by a coordinated increase in both at 
later times (Fig. 2.4E).  Overall, transgene arrays that made initial contact with a larger 
speckle (> 0.6 µm2) showed shorter time lags (typically 0-2 min) between first contact 
and transcript accumulation above background than the time lags (typically 3-7 min) 
observed for transgene arrays that made initial contact with a smaller speckle ( <0.6 µm2) 
(Fig. 2.4F).  
 Our results suggest a dose response relationship in which the ability of nuclear 
speckles to initially boost HSP70 transgene transcription increases with speckle size.  At 
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higher levels of transcription, transcript accumulation levels increase in parallel with 
speckle size, suggesting again some type of functional connection between nuclear 
speckle size and transcription levels of surrounding chromatin. 
We next asked whether preventing the increased frequency of HSP70 transgene 
association with nuclear speckles after heat shock would effect transgene expression.  We 
used latrunculin A treatment which blocks the normal increase in HSP70 transgene 
association from ~20-30% to nearly 80% after heat shock (Fig. 2.1H).  Whereas the 
average level of transgene transcription is greatly decreased, this correlates with the 
reduced percentage of transgenes associated after heat shock with nuclear speckles (Fig. 
2.4G-H).  After latrunculin A treatment, the low level of transcription for the ~70% of 
transgene arrays not associated with nuclear speckles (Fig. 2.4H) is similar to the 
transcription levels observed in the small fraction of transgene arrays not associated with 
nuclear speckles in control cells (Fig. 2.4G).   Robust transcription at similar levels to 
control cells, when comparing association with similar size speckles, is still observed for 
the ~30% of transgene arrays in contact with nuclear speckles (Fig. 2.4G-H).  
Importantly, latrunculin A treatment does not appear to inhibit transcription per se.  
These results further support a model in which HSP70 transgene association with nuclear 
speckles facilitates their transcriptional activation.   
  In summary, we have demonstrated long-range, directed movements of HSP70 
transgenes towards nuclear speckles occurring through an active, force-generating 
mechanism, with nuclear speckle contact followed by increased transcription.    
 Previously, long-range motion of a peripheral chromosome site away from the 
nuclear periphery was observed after artificial tethering of an acidic transcriptional 
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activator (1), but the physiological relevance to natural gene activation was questionable.  
Here, we have demonstrated long-range movements with nearly 4-fold higher velocity 
(1.14 versus 0.31 µm/min) through activation of a transgene from a naturally occurring 
promoter sequence.   
 Long-range movement is not synonymous with directed movement.  Varied 
mechanisms could be imagined as giving rise to long-range, but randomly directed 
motion.  Coherent movements of chromosome regions over micron-scale distances has 
been suggested as due to elastic coupling, through chromatin, within the nucleus (13).  A 
“search and capture” type model in which random motion was terminated by transgene 
binding to nuclear speckles could give the appearance of directed motion.  A long-range, 
directed movement of a U2 snRNA mini-gene array towards coiled bodies has been 
reported (9), yet this study was based largely on two examples of long-range movement, 
unaccompanied by any statistical analysis, making it difficult to conclude directed versus 
random motion.  Here, statistical analysis of multiple trajectories supported a vectorial 
directionality to long-range movements.  Moreover, statistical analysis taking into 
account the measured solid angle of all trajectories that would result in contact versus no 
contact with nuclear speckles strongly supported a directed movement towards nuclear 
speckles rather than a search and capture model. 
 The strongest indication of a directed chromosome movement towards nuclear 
speckles is the accompanying chromatin stretching tangential to the direction of 
movement that appears shortly before or during the actual period of chromosome motion.  
This stretching strongly argues for a force pulling on the chromatin in the direction of 
motion.  In contrast, an alternative model in which a chromatin fiber stretched between 
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another anchor point and the nuclear speckle might recoil elastically towards the nuclear 
speckle after release of the chromatin from the anchor point instead would predict 
maximum stretching prior to motion, with a progressive relaxation of tension and 
stretching during movement. 
 Finally, our results may bridge two previous models for nuclear speckle function.  
Alternatively, nuclear speckles have been proposed to act as hubs for a subset of 
transcriptionally active genes (4) versus as storage sites for RNA processing components 
(14). During heat shock we see evidence for both roles.  As with other conditions 
resulting in a general transcriptional inhibition, heat shock is accompanied by a reduced 
number and rounding of nuclear speckles.  Yet, our results demonstrate a functional 
enhancement of HSP70 transgene transcription resulting from proximity with nuclear 
speckles through an as yet unknown mechanism.  We note that the SRSF2/SC35 SR-
splicing factor, concentrated in nuclear speckles, has been shown to play a role in 
transcriptional pause release and transcriptional activation (15).  It is tempting to 
speculate that the initial rise in speckle size we see frequently preceding the first 
detection of nascent transcripts above background, as well as the coordinated increase in 
speckle size and transcription we observe at later times, reflects a flux of speckle 
components back and forth between the transcription site and the speckle, with local 
storage and accumulation of factors at the speckle.  Cycles of modification of speckle 
components in the speckle followed by reversal of these modifications at the site of 
transcription might explain the functional coupling between speckles and transcription at 
neighboring genes.  These cycles could include, for instance, phosphorylation of SR 
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proteins in the speckle and dephosphorylation at the transcription site as previously 
suggested (16). 
 Several special features of our cell system likely facilitated our experiments.  By 
using a plasmid transgene array that prior to heat shock targets preferentially to the 
nuclear periphery, we were able to maximize the average distance of the array to nearby 
speckles.  This was crucial for distinguishing directed movements from the rapid 
“constrained diffusion” type movements (11) observed at all interphase chromosome 
sites.   Second, previously we were puzzled by the delayed and asynchronous 
transcriptional induction of plasmid HSP70 transgene arrays as compared to BAC HSP70 
transgene arrays.  Now it appears this delay may be related to the time required for these 
plasmid transgene arrays to become associated with nuclear speckles.  We suspect the 
heterochromatin nature of the plasmid transgene arrays accentuates the positive impact of 
speckle proximity for transcriptional activation, thus highlighting the capacity of nuclear 
speckles to enhance transcription.   Experiments are now in progress to examine the 
relationship between transcriptional induction and speckle proximity for BAC and 
endogenous HSP70 genes. 
 We anticipate that our results and experimental system will facilitate future 
experiments aimed at elucidating the molecular mechanism underlying this movement 
and the transcriptional enhancement resulting from speckle association.  A significant 
fraction of endogenous genes associate with nuclear speckles when transcriptionally 
active; we speculate that similar active movements may play a role in the transcriptional 
regulation of those genes that change their nuclear localization upon transcriptional 
activation.  We also anticipate that the machinery enabling such long-range, active 
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movements may be involved in multiple aspects of genome organization and nuclear 
architecture. 
 
 
Experimental Procedures: 
 
Plasmids and BACs were stably transfected into CHO DG44 cells expressing 
EGFP-LacI (clone 7) cells (5).  The pSP14-14-5’UTR-MS2 plasmid was stably 
transfected using 7.5µg/ml puromycin (Sigma) for selection to generate the cell clone 
pSP14_5’UTR_MS2_HSP70_42 (C42).  C42 was transfected with the EGFP labeled 
SON-BAC and selected using 200 µg/ml Zeocin to generate a cell clone C42-165J2-
C16_C4_1. The above generated cell clone was transfected with either CENPA-mCherry 
or Ub-MS2bp-mCherry and selected using 400 µg/ml G418 selection, to generate either 
C42-165J2-CENPA-mCh-C36 or C42-165J2-UbMS2mCh-B respectively.  The 
constructs mRFP-actin-NLS and mRFP-G13R actin-NLS[1] were transiently transfected 
into cells and speckle association analyzed after 48 hrs.  Cells were treated with either 
Latrunculin A (Calbiochem) for 5min or Jasplakinolide (Calbiochem) for 30min at a final 
concentration of 1µM, followed by heat shock for 30 min.  An Applied Precision OMX 
microscope with EMCCD cameras was used for live cell microscopy and a Personal 
Deltavision for fixed cell microscopy.  Data was deconvolved using Applied Precision 
SoftWorx software. 
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Figures: 
 
Figure 2.1. Simultaneous visualization of HSP70 transgenes, nascent transcripts, 
and nuclear speckles.   
 
 (A-B) HSP70 plasmid pSP14-14-5’UTR-MS2 (A) and the modified SON BAC (B) 
transgenes.  (C-F) DAPI-stained nuclei (blue) versus HSP70 transgenes (GFP-LacI, 
bright grey-scale), speckles (GFP-SON, less bright grey-scale) and HSP70 transcripts 
(MS2-binding protein-mCherry, red):  After heat shock (HS), nascent transcripts 
(arrowhead) accumulate near speckle (C).  Peripheral transgenes (arrowheads) prior to 
HS (D).   HSP70 transgenes (arrowheads) not associated (E) or associated (F) with 
speckles.  (G) Speckle association index before or after 30 min HS.  (H) Disrupting 
nuclear actin polymerization abolishes HS-induced speckle association. SEM error bars, 
scale bar = 2µm. 
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Figure 2.2. Live-cell imaging reveals long-range, directed motion of HSP70 
transgenes towards nuclear speckles. 
 
 
 
 
(A-C) HSP70 transgene (yellow arrowheads) movements during heat shock.  (B-C) 
Transgene movement relative to centromeres (mCherry-CENPA, white arrowheads) rules 
out nuclear rotation.  (D-H) Transgene trajectories projected over time.  (I) Directed 
(middle) versus random motion (bottom).  (J) Histogram of angular deviations between 
trajectory direction at each time point and vector (I, top) drawn between initial and final 
transgene positions.  (K) Histogram of total trajectory lengths (sum of vector lengths; I, 
bottom) divided by net displacement distances (I, top).  Time is minutes (‘) after heat 
shock.  Scale bar= 2 µm.  See also Figure A1 and Videos E1,E2, and E3. 
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Figure 2.3. Transgene chromatin stretching coincident with and parallel to long-
range movements. 
 
 
 
 (A-D) HSP70 transgenes (arrowheads) show stretching during (A,B) or immediately 
proceeding (C) long-range movements; stretching relaxes after long-range movement 
stops (A,D).  Insets (A-D) show 2-fold enlarged regions surrounding the transgene array.  
(C) Increasing distance between two spots (arrowheads) demonstrated with display 
(bottom) of 8 consecutive optical sections (OS), separated by 200 nm focus steps. Time 
shown is minutes (‘) after heat shock.  Scale bar= 2 µm.  (E) Histogram (bottom) showing 
near-zero angle (top) between direction of transgene stretching and movement direction.  
See also Videos E4, E5. 
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Figure 2.4. HSP70 transgene transcription is facilitated by nuclear speckle 
association 
 
 
 
 
 
(A-B) Transcript signal (mCherry-MS2-binding protein, red) increases above background 
levels shortly after first contact of transgene array (bright green) with nuclear speckle 
(lighter green).  Top inset- green channel; Bottom inset- red channel. Time is min after 
heat shock. Scale bar= 2 µm.  (C-D) Two examples of speckle area (blue) plotted versus  
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Figure 2.4 cont. 
 
integrated MS2-binding protein signal (red, “transcript amount”) in arbitrary units (a.u.) 
as function of time after initial transgene contact with a nuclear speckle.  (E) Speckle size 
versus transcript signal as function of time after speckle first contact averaged over all 
observations.  (F) Histograms for the delay between first contact with speckle and 
appearance of transcript signal plotted for transgene arrays that contact small speckles (< 
0.6 µm2, blue) versus large speckles (>0.6 µm2, red).  Speckle size is measured at time of 
first contact.  (G-H) Integrated transcript signals from each of 32 different cells (x-axis) 
30 min after heat shock ordered by increasing speckle size.  Low transcript levels are 
observed for transgene arrays not associated with nuclear speckles.  A much larger 
fraction of transgenes arrays were not associated with nuclear speckles after latrunculin A 
treatment (H) as compared to control cells (G).  Speckle associated transgene arrays show 
comparable transcript levels between control (G) and latrunculin A treated cells (H) if 
transgene arrays are grouped according to the size of their associated nuclear speckles. 
See also Video E6.  
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CHAPTER 3 
 
β-Globin Cis Elements Determine Differential Nuclear Targeting Through 
Epigenetic Modifications1 
 
Abstract: 
 
Increasing evidence points to nuclear compartmentalization as a contributing 
mechanism for gene regulation, yet mechanisms for compartmentalization remain 
unclear. In this paper, we use autonomous targeting of bacterial artificial chromosome 
(BAC) transgenes to reveal cis requirements for peripheral targeting. Three peripheral 
targeting regions (PTRs) within an HBB BAC bias a competition between pericentric 
versus peripheral heterochromatin targeting toward the nuclear periphery, which 
correlates with increased H3K9me3 across the beta-globin gene cluster and locus control 
region. Targeting to both heterochromatin compartments is dependent on Suv39H-
mediated H3K9me3 methylation. In different chromosomal contexts, PTRs confer no 
targeting, targeting to pericentric heterochromatin, or targeting to the periphery. A 
combination of fluorescent in situ hybridization, BAC transgenesis, and knockdown 
                                                
1 This chapter appeared in its entirety in Journal of Cell Biology. Qian Bian#, Nimish 
Khanna#, Jurgis Alvikas, Andrew S. Belmont  (2013) Beta-Globin Cis Elements 
Determine Differential Nuclear Targeting Through Epigenetic Modifications. J Cell Biol. 
2013 Dec 9;203(5):767-83. doi: 10.1083/jcb.201305027. Epub 2013 Dec 2. PMID: 
24297746 
 
Author Contributions: # Q.B. and N.K. contributed equally to this paper. N. K., Q.B., 
and J.A. carried out experiments for figures 3.1-3.4. N.K. carried out experiments for 
figures 3.5-3.10. Q.B. carried out experiments for figures 3.S1 and 3.S2. N.K. carried out 
experiments for figures 3.S3-3.S5. N.K., Q.B., and A.S.B. designed the experiments and 
analyzed the results. A.S.B. supervised the study and together with N.K. and Q.B. wrote 
the paper. 
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experiments reveals that peripheral tethering of the endogenous HBB locus depends both 
on Suv39H-mediated H3K9me3 methylation over hundreds of kilobases surrounding 
HBB and on G9a mediated H3K9me2 methylation over flanking sequences in an adjacent 
lamin-associated domain. Our results demonstrate that multiple cis-elements regulate the 
overall balance of specific epigenetic marks and peripheral gene targeting. 
 
Introduction: 
Spatial compartmentalization of chromatin may contribute to regulation of 
genome function (9,14,25).  In many higher metazoans, transcriptionally silent genes are 
preferentially located towards the nuclear periphery, with more active genes 
preferentially located in the nuclear interior (27,32).  Recent genome-wide studies using 
the DamID method have mapped preferred genome-lamin interactions in Drosophila and 
cultured mammalian cells, suggesting increased interaction of transcriptionally inactive 
regions with the nuclear lamina (27).  In human fibroblasts, more than 1300 sharply 
defined domains with sizes of 0.1- 10 megabases were shown to preferentially interact 
with the nuclear lamina (16).  These lamina-associated domains (LADs) are enriched in 
repressive chromatin marks and genes with low expression-levels.  Similarly, some 
inactive genes localize to peri-centromeric heterochromatin (PCH).  In cycling primary B 
lymphocytes or developing T cells, PCH association correlated with heritable gene 
silencing (6,17). 
Many developmentally regulated genes locate at the nuclear periphery in their 
silent state but reposition to the nuclear interior upon gene activation, suggesting that 
peripheral gene localization may help establish and/or maintain developmental gene 
 
 
 36 
repression (21,22,29,39,41).   In yeast, tethering to the nuclear periphery restored gene 
repression to a defective silencer (1).  In mammalian cells, similar tethering experiments 
(12,24,30) have suggested that gene repression associated with tethering was promoter 
specific and quantitative, modulating transcription rather than turning it from on to off.  
Little is known about how endogenous gene loci are targeted to the nuclear 
periphery.  Different models could explain targeting of single copy gene loci to the 
nuclear periphery.  Peripheral targeting of transcriptionally inactive genomic regions 
could be the default, with transcriptionally active genome regions actively targeted to the 
nuclear interior (Model 1).  Alternatively, specific DNA sequences, and/or proteins 
binding to these sequences, might target chromatin to the nuclear periphery either 
through direct molecular interactions with nuclear envelope proteins (Model 2) or 
through establishment of a distinct, epigenetically-marked chromatin domain, with 
peripheral targeting downstream of this chromatin domain establishment (Model 3). 
 Two very recent studies have begun to address these possible molecular 
mechanisms.  Supporting model 2, an autonomous BAC targeting approach identified 
"Lamin Associated Sequences" (LAS) conferring peripheral targeting from the IgH and 
Cyp3a multi-gene loci (43).  These LAS contained GA motifs binding the cKrox GAGA 
transcription factor, which was proposed to peripherally tether these sites through 
interactions with the inner nuclear membrane protein Lap2β and HDAC3.  Supporting 
model 3, tethering of repetitive gene arrays to the nuclear periphery in C. elegans was 
dependent on H3K9 methyltransferases, while wild-type chromosome arm regions with 
high levels of H3K9 methylation showed reduced interactions with the nuclear lamina 
after H3K9 methylation knockdown (35). 
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 The high compaction of large-scale chromatin folding complicates identification 
of cis and trans elements that target chromosome regions to particular nuclear 
compartments. Active targeting via a single sequence region may lead to apparent 
targeting of 100s to 1000s of kb of adjacent chromosomal sequence, depending on the 
resolution of the imaging modality used to map intranuclear localization.  Conversely, 
redundant targeting mechanisms operating over adjacent chromosome regions may make 
identification of individual targeting mechanisms difficult. 
 Here we use the mammalian beta-globin gene (HBB) locus to identify cis 
requirements for chromosome targeting to the nuclear periphery.  HBB targets either to 
the nuclear periphery (18,29) or to pericentric heterochromatin (PCH) (6) in several cell 
types where it is inactive.  By analyzing the autonomous nuclear periphery targeting of 
BAC transgenes, we identify a Suv39H, H3K9me3 dependent pathway involved in 
tethering the HBB locus to the nuclear periphery, in competition with targeting to PCH, 
that acts separately from an independent G9a, H3K9me2 dependent pathway, which 
tethers adjacent LAD sequences to the periphery.   
 
Results: 
 
A BAC containing the human beta-globin locus autonomously targets to the nuclear 
periphery in mouse fibroblasts: 
 Multiple, co-integrated copies of a 207kb BAC (CTD-2643I7) containing the 
human beta-globin locus target to the nuclear periphery in mouse ES cells largely 
independent of their chromosomal insertion sites (33).  This autonomous targeting 
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mirrors the peripheral targeting of the endogenous mouse beta-globin locus in mouse ES 
cells (18).   
 We applied this autonomous targeting assay to dissect cis elements conferring 
targeting to the nuclear periphery (Fig. B.1).  Inserting a lac operator 256mer into the 
BAC and expressing GFP-lac repressor (GFP-LacI) provided direct visualization of 
integrated BAC transgene location. To further facilitate this assay, we used mouse NIH 
3T3 cells, an immortalized, fibroblast cell line with high transfection and subcloning 
efficiency. 
 Fluorescent in situ hybridization (FISH) on human BJ-hTERT cells revealed 
>50% of endogenous beta-globin loci within 0.5µm from the nuclear lamina (Fig. 3.1a, 
g).  Measurements were made from single optical sections from the nuclear mid-section.  
Peripheral localization of the endogenous beta-globin locus also was observed in mouse 
NIH 3T3 fibroblasts (Fig. 3.1b, g).  No significant peripheral localization was observed 
for the endogenous human alpha-globin locus, flanked by multiple housekeeping genes 
(Fig. 3.1c, g).       
 The peripheral localization of human beta-globin (HBB) BACs in mouse 3T3 
fibroblasts similarly mirrored the peripheral localization of endogenous mouse and 
human HBB loci in fibroblasts.  In 4/5 randomly selected, stable clones, BAC transgenes 
located within 0.5µm from the nuclear periphery in 30-64% of the cells (Fig. 3.1d-f) with 
the transgene radial positioning distribution recapitulating the endogenous beta-globin 
locus distribution (Fig. B.2). Peripheral localization in all clones was significantly higher 
than the 14.8% predicted geometrically for an average-sized, 2D elliptical nucleus (16 
and 11µm diameters) (Fig. 3.1g).  The lac operator repeat does not contribute to this 
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peripheral localization; we observed by FISH a 50% peripheral localization of HBB BAC 
transgenes lacking an inserted lac operator repeat in a mixed population of stable clones 
(Fig. 3.1g).  In contrast, DHFR BAC transgene arrays showed a 5-16% peripheral 
localization (Fig. 3.1g).  Previously, we observed interior nuclear localization for lac 
operator tagged BAC transgene arrays carrying MT, HSP70, DHFR, or alpha-globin gene 
loci (19,33).  
 
Beta-globin genes and regulatory regions are not required for peripheral targeting: 
 Movement of the beta-globin genes from the nuclear periphery to interior 
accompanies their transcriptional activation during erythrocyte maturation (29).  The 
human beta-globin gene cluster consists of five globin genes (HBE1, HBG1, HBG2, 
HBD and HBB).  The 39.5 kb "Hispanic" deletion upstream of the beta-globin gene 
cluster causes profound alteration of beta-globin expression (4.10).  The most important 
regulatory region overlapping with the Hispanic deletion is the LCR (locus control 
region) containing six DNase I hypersensitive sites (HSs), located 6-22 kb upstream of 
the HBE1 gene and required for high expression level of all beta-globin genes (4).  The 
27 kb region upstream of the LCR ( Upstream Hispanic Region or "UHR"), may also 
contain functional elements for beta-globin gene regulation.  Two erythroid-specific 
DNase I hypersensitive sites (HSs), the 3’HS1 located between the HBB and olfactory 
receptor OR51V1 genes and HS-110 located 110kb upstream of HBE1 between olfactory 
receptor genes OR51B6 and OR51M1, have also been implicated in beta-globin 
regulation (11,26).  
 
 
 40 
 We used λ-red BAC recombineering to remove specific sequences from the HBB 
BAC (38) (Fig. 3.2, Fig. B.3).  Cycles of galK insertion and removal using positive and 
negative selection allowed repeated rounds of deletions.  Deleting the LCR (D1), the 
beta-globin gene cluster (D2), as well as the entire beta-globin locus (D5) including the 
UHR and 3’HS1 sequences (D5) all failed to eliminate peripheral targeting (Fig. 3.2a-b).  
As described below, HS-110 also is not required (double deletion D8D11). 
 
Three cis regions are each sufficient for HBB BAC peripheral targeting:  
 Instead, deleting the entire 80 kb region (D7) upstream of the beta-globin gene 
cluster and LCR eliminated peripheral targeting (Fig. 3.2a, c, f).  This peripheral targeting 
capability was further narrowed to a 56 kb region by the D4 deletion (Fig. 3.3,a,c,f).  As a 
negative control, a double deletion (HBBD5D7) (Fig. 3.2a) localized to the nuclear 
interior (Fig. 3.2c,f).  This BAC double deletion removes nearly the entire human DNA 
insert but retains the lac operator repeat, selectable marker, and vector backbone. 
 Previous studies in human lung fibroblasts mapped a 32kb LAD region at the 3' 
end of the HBB BAC (Fig. 3.2a) (16).  Neither the LAD (D8) nor the LAD plus boundary 
region containing HS-110 and a CTCF binding site cluster (D9) were required for 
peripheral targeting.   This means either the LAD region does not contain a peripheral 
targeting sequence or functionally redundant targeting sequences exist outside the LAD 
region. 
 Further dissection revealed three, functionally redundant peripheral targeting 
regions (PTRs) (Fig. 3.2e).  The 6.3 kb PTR1 was identified using nested deletions D11 
through D14 combined with the D8 deletion (Fig. 3.2e-g).  The triple deletion 
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D8D13D22 confirmed that additional sequences flanking PTR1 were not required for 
targeting (Fig. 3.2e,f).  The 23 kb PTR2 was revealed by double deletion D8D17, which 
removed PTR1 but preserved peripheral targeting (Fig. 3.2e,f).   PTR3 was mapped to the 
32 kb corresponding to the intersection of the D8 and D4 deletions, based on the 
peripheral targeting of the D10 deletion, the loss of peripheral targeting with the D4 
deletion, and the peripheral targeting of the combined D5 and D10 deletions (Fig. 3.2c,d).  
Only PTR3 is contained within the LAD (Fig. 3.2e). 
 
Competition between PCH and peripheral targeting: 
 Association of inactive genes with PCH occurs in a number of cell types (6,9,13).  
This includes association of the inactive beta-globin locus with PCH in cycling human 
lymphocytes (6), and localization of the inactive beta-globin locus to both centromeres 
and the nuclear periphery in mouse erythroleukemia (MEL) cells (13).   
 Interestingly, our deletion analysis revealed competition between HBB BAC 
targeting to the nuclear periphery versus PCH.  In mouse cells, PCH clusters into DNA 
dense bodies called chromocenters.  BAC deletions that removed all three PTRs (D4 and 
D8D14) lost peripheral targeting activity while showing a commensurate increase in 
chromocenter association (Fig. 3.3a-b).   
 These observations prompted reexamination of HBB BAC localization.  Cell 
clones with different chromosome integration sites, and different HBB peripheral 
targeting frequencies, showed a near constant sum of chromocenter or peripheral 
targeting (Fig. 3.3c).  A similar, near constant sum for peripheral and chromocenter 
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targeting was observed for HBB BAC deletions preferentially targeting to the periphery 
(D5) or to the chromocenter (D4) (Fig. 3.3c).  
 RT-qPCR measurements of beta-globin and olfactory gene expression, 
normalized by copy number, revealed similar expression for BAC transgenes localizing 
either to the periphery or the PCH (Fig. 3.3d).  HBB transgene expression levels were 
very close to copy number normalized expression levels for the endogenous mouse HBB 
gene (Fig. 3.3e).  An ~3 fold expression increase was observed for the selectable marker 
in the BAC targeted to the PCH versus the nuclear periphery (KN, Fig. 3.3d).  
 
PTR intra-nuclear targeting is context specific: 
 The 6.3 kb PTR had no effect on plasmid transgene positioning (Fig. 3.4a), 
suggesting a position effect for PTR targeting activity.  Multi-copy plasmid arrays are 
known to show strong transgene silencing; this likely is related to their abnormally 
condensed chromatin conformation (3,5).   
 Position effect modulation of PTR activity also is implied by the clonal variation 
in peripheral targeting of HBB BACs inserted at different chromosome sites.  This 
position effect could arise either from a dominant targeting activity of endogenous 
sequences flanking the BAC transgenes, and/or to a long-distance, antagonistic activity of 
these flanking sequences on the cis targeting elements within the PTR.   
 To produce an experimentally reproducible position effect, we co-transfected 
DHFR and HBB BAC transgenes and isolated clones in which these BACs co-integrated. 
DHFR BAC transgenes reconstitute an open large-scale chromatin conformation and 
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confer position-independent, copy number dependent expression of a reporter gene 
independent of chromosome insertion site (5).   
 Surprisingly, clones carrying co-integrated DHFR and HBB BACs transgenes 
showed preferential targeting not to the periphery, where HBB BACs localized, and not 
to the nuclear interior, where DHFR BACs localized, but instead to the PCH (Fig. 3.4b-
c).  PCH association frequencies were similar to that observed for the HBBD4 BAC 
lacking all PTRs, suggesting that flanking DHFR BAC sequences inhibit PTR peripheral 
targeting activity. 
 These results suggested an epigenetic component to PTR targeting.  We next 
tested PTR1 within the context of BACs containing large, gene-free DNA regions.  First, 
as a positive control, we showed that random insertion of PTR1 into HBBD4 by Tn5 
transposition restored peripheral targeting (Fig. 3.4d).  Therefore positioning of the beta-
globin locus by PTR1 does not require a fixed position of PTR1 within the HBB BAC.   
 We then inserted PTR1 via Tn5 transposition into BACs containing two different, 
~200 kb human sequences.  CTD-2207K13 contains an insert from a large gene desert 
region, whereas RP11-2I1 contains an intergenic sequence from a gene-rich RIDGE (15) 
region.  Both "neutral" BACs with control transposons containing only the Lac operator 
repeat and selectable marker showed interior nuclear localization.  Adding PTR1 to the 
CTD-2207K13 BAC produced no change in interior localization (Fig. 3.4e).  However, 
inserting PTR1 into the RP11-2I1 BAC retargeted these BAC transgenes from the nuclear 
interior to the PCH (Fig. 3.4f). 
 Thus PTR1 confers peripheral targeting to the HBBD4 BAC, which would 
otherwise target to the PCH, but PCH targeting to the RP11-2I1 BAC, which would 
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otherwise target to the nuclear interior, strongly suggesting an epigenetic mechanism for 
PTR targeting.  
 
Targeting to the nuclear periphery correlates with BAC co-localization with 
H3K9me3 foci: 
 Repressed genes are known to associate with both the nuclear periphery and the 
PCH.  We therefore used immunofluorescence to examine co-localization of BAC 
transgenes with specific heterochromatin marks.  HBB BACs did not obviously associate 
with H3K27me3 foci, but did show elevated H3K9me3 immunostaining (Fig. 3.5a-c).  
The shape and size of the elevated H3K9me3 immunostaining corresponded closely to 
the shape and size of the GFP signal, suggesting an increased H3K9me3 modification 
over the BAC transgene array itself (~1 Mbp in size for the ~5 BAC copies in the HBB-
C3 clone).    ~80% of HBB transgenes showed "strong" H3K9me3 immunostaining 
independent of peripheral versus interior localization. All full-length HBB BAC and 
HBB BAC deletions targeting to the periphery showed elevated H3K9me3 
immunostaining, whereas all HBB BAC deletions that did not target to the periphery 
showed significantly lower levels of H3K9me3 (Fig. 3.5d-g).  
  Inserting PTR1 to a new location within the HBBD4 BAC (D4-PTR1) restored 
peripheral localization and elevated H3K9me3 staining (Fig. 3.5g).  Co-integration of 
HBB BAC transgenes with the active, housekeeping DHFR BAC transgenes led to 
reduced H3K9me3 over the transgenes (Fig. 3.5g). 
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H3K9me3 ChIP over PTR1 and the HBB locus and its correlation with H3K9m3 
immunofluorescence and nuclear localization: 
 To provide an independent, biochemical measure of the H3K9me3 modification, 
we used qPCR to quantitate H3K9me3 chromatin immunoprecipitation (ChIP).  Primer 
pairs were spaced every ~5 kb over the HBB BAC insert except for PTR1 where we used 
6 primer pairs spaced over 6.3 kb (Fig. 3.6a).  Three biological replicates of ChIP over 
the HBB BAC transgene in cell clone HBBC3 (~5 BAC copies estimated by qPCR) 
showed consistently elevated levels over PTR1 at both 5' and 3' PTR1 ends, with two 
primer pairs (28-29) showing peak values over the entire BAC (Fig. 3.6b).  To normalize 
ChIP data between different experiments, we linearly mapped measurements on a 0 to 1 
scale: "0" corresponded to % input values for the GAPDH promoter negative control 
whereas "1" corresponded to % input values measured for the IAP transposon positive 
control.  The GAPDH promoter H3K9me3 ChIP modification level is among the lowest 
in the genome, whereas the IAP transposon positive control H3K9me3 ChIP modification 
level, higher than that observed over major and minor satellite and LINE-1 repeats (data 
not shown), represents the high end for H3K9me3 genomic modification. 
 Normalized ChIP values showed an improved reproducibility across the HBB 
BAC transgene.  Because PTR1 was oversampled relative to other HBB BAC sequences, 
we may have missed localized H3K9me3 peaks in PTR2 and PTR3.  Elevated H3K9me3 
levels were also seen over PTR1 inserted into the HBBD4 BAC with all PTRs removed 
(HBBD4+PTR1, clone A3 containing ~3 BAC copies) (Fig. 3.6c).   
 An observable increase in H3K9me3 immunostaining over BAC transgenes 
would require increased H3K9me3 levels over large regions of the HBB BAC.  To 
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compare ChIP with immunofluorescence data, we estimated average H3K9me3 levels 
(weighted by probe separation distances) over the HBB BAC.  Average ChIP values were 
nearly 2 fold higher over the intact HBB BAC versus the HBBD4 BAC with all PTRs 
deleted; adding PTR1 back to the HBBD4 BAC increased average ChIP levels close to 
that of the full length HBB BAC (Fig. 3.6c,e).   
 To compare ChIP and immunofluorescence results, we normalized 
immunostaining intensity values using a similar two point linear interpolation procedure.  
H3K9me3 immunostaining intensities over DAPI stained regions devoid of obvious 
H3K9me3 foci were mapped to "0", while immunostaining values over chromocenters 
were mapped to "1".  H3K9me3 immunostaining intensities directly over the GFP-LacI 
peak intensity were renormalized to this 0-1 scale.  Given the resolution of light 
microscopy, we expected spreading of the high H3K9m3 signal from the intensely 
stained chromocenters would artificially elevate intensity values over transgenes at the 
chromocenter periphery.  We therefore made measurements over BAC transgenes not 
associated with chromocenters. 
 Normalized, immunostaining H3K9me3 levels were similar to normalized ChIP 
H3K9me3 levels (Fig. 3.6f).  ChIP and immunofluorescence H3K9me3 values were 
significantly higher for the full length HBB BAC compared to the HBBD4 BAC deleted 
of PTRs.  No significant difference in average ChIP or immunofluorescence values were 
observed between the full length HBB BAC and the HBB BAC deleted of PTRs but with 
PTR1 added back (D4+PTR1). 
 PTR1 containing transgenes that target to the nuclear interior show significantly 
lower PTR1 average H3K9me3 levels compared to PTR1 levels within HBB or 
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HBBD4+PTR1 BACs that target to the nuclear periphery (Fig. 3.6g).  PTR1 H3K9me3 
levels in co-integrated HBB and DHFR BACs were similar to levels in full length HBB 
BAC transgenes despite their different nuclear targeting (Fig. 3.6d,g).  However, over the 
non-PTR regions (primer pairs 2-18) average H3K9me3 ChIP levels were significantly 
lower in the co-integrated DHFR/HBB BAC arrays than peripherally targeted, HBB or 
HBBD4 +PTR1 BAC arrays, but similar to levels in the HBBD4 BAC that also targeted 
to the PCH (Fig. 3.6h). 
 
H3K9 methylation is required for peripheral and PCH HBB BAC targeting: 
 Cells were infected with pooled lentiviruses expressing shRNA directed against 
both Suv39H1 and Suv39H2 and selected using puromycin.  A significant fraction of 
cells surviving drug selection showed weaker and more diffuse H3K9me3 staining than 
control cells.  In cell clone C3 containing the HBB BAC, infected cells were classified 
into three categories based on H3K9me3 staining levels (Fig. 3.7a-c).  A dose dependent 
reduction of peripheral targeting was observed with a drop from 61% to 23% peripheral 
association between the "normal" and "none" categories (Fig. 3.7d).  A similar dose 
dependent reduction in PCH targeting was observed in cells (clone C40.10) carrying the 
HBBD4 BAC with all PTRs deleted (Fig. 3.7e-h).   
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Combined H3K9me3, H3K9me2 knockdown detaches HBB locus from the 
periphery- H3K9me2 or H3K9me3 dependent peripheral interactions over spatially 
separate chromosome regions: 
 We observed no change in peripheral localization of the endogenous beta-globin 
locus in mouse 3T3 cells (data not shown) or human Tig3ET fibroblasts (Fig. 3.8f-g) 
after Suv39H1/H2 RNAi knockdown.  Previously we estimated compaction levels ~1-3 
Mbp/µm for large-scale chromatin fibers (19,36), while our criterion for peripheral 
localization is a signal <0.5 µm from the nuclear.  We hypothesized an additional non-
H3K9me3 dependent tethering mechanism(s) acting on DNA flanking the HBB locus 
preventing displacement of HBB >0.5 µm from the periphery.  
 We identified two GA motif clusters within +/- 1 Mbp of the HBB gene (Fig. 
3.8a), using the same motif-finder software as used previously (43).  The first, in an inter-
LAD 800 kb 5' to HBB (within CTD-2547L21), shows interior localization (data not 
shown).  The second, 200 kb 3' to HBB and in an adjacent, ~1 Mbp LAD (within RP11-
715G8 BAC, Fig. 3.8a), is peripherally located (data not shown).  Neither cKrox siRNA 
single knockdown nor cKrox, Suv39H1, and Suv39H2 triple knockdown disrupted the 
peripheral localization of HBB or RP11-715G8 BAC probes (Fig. B.4).  Western blots 
showed knockdown of ~95% for cKrox, whereas H3K9me3 knockdown was verified by 
immunostaining (Fig. B.4). 
 H3K9me2 has been proposed to anchor LADs to the nuclear lamina and is 
enriched at the nuclear periphery (Kind et al., 2013);  however, HBB BAC transgenes 
(C3 clone) colocalized with H3K9me3 but not H3K9me2 staining (data not shown).  
H3K9me3 is also enriched at the nuclear periphery at comparable or even higher levels 
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than H3K9me2 in human TIG3 and WI-38 and mouse NIH 3T3 fibroblasts (Fig. B.5).  
Foci of strong, peripheral H3K9me3 or H3K9me2 immunostaining frequently appear 
anti-correlated, suggesting independent targeting. 
 Based on knockout experiments and mass spectroscopy, G9a appears responsible 
for ~50% of the total H3K9me2 signal (28).  This H3K9me2 reduction is comparable to 
what we observed after G9a drug inhibition (Fig. B.4) or shRNA knockdown (data not 
shown), and similar to that observed by others (20,40).  H3K9me2 knockdown using G9a 
inhibitors BIX01294 or UNC0638 (data not shown) did not disrupt the peripheral 
localization of HBB or RP11-715G8 BAC probes (Fig. B.4).  However, simultaneous 
G9a inhibition (or shRNA knockdown, data not shown) and H3K9me3 knockdown by 
Suv39H1/H2 siRNA significantly reduced HBB peripheral localization (Fig. 3.8g).   
 Painting the ~1 Mbp LAD region with 4 BAC probes, we simultaneously 
visualized both LAD and HBB regions (Fig. 3.8a-e).  In control and single knockdown 
cells, in a given cell both the LAD and HBB regions typically were located either at the 
periphery or the interior (Fig. 3.8 b-c, f-g).  After double knockdown of H3K9me3 and 
H3K9me2, the HBB region separated >0.5 µm from the periphery in ~70% of cells (Fig. 
3.8f,i).  A polarized orientation- peripheral tethering of the distal LAD region, separation 
of the remainder of the LAD from the periphery, and the HBB locus >0.5 µm from the 
periphery and more interior than the LAD- was observed in ~15% of cells (Fig. 3.8i).   
 These results suggest three independent mechanisms for peripheral targeting near 
the HBB locus- a Suv39H1/H2 dependent mechanism operating over the HBB locus, a 
G9a dependent mechanism operating over the proximal region of the adjacent LAD, and 
likely a third, uncharacterized mechanism anchoring the distal LAD region (Fig. 3.10a). 
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 To more clearly establish anchoring of LAD regions to the periphery through a 
G9a dependent, Suv39H1/H2 independent mechanism, we visualized stably integrated, 
lac operator tagged RP11-715G8 BAC transgenes in a mixed clonal cell population.  
RP11-715G8 BAC transgenes were peripherally located in 50% of cells.  Suv39H1/H2 
shRNA had no effect on RP11-715G8 BAC peripheral localization, but BIX01294 G9a 
inhibition eliminated peripheral targeting to background levels (Fig. 3.9c).  In contrast, 
G9a inhibition had no effect on peripheral localization of HBB transgenes (C3 cell 
clone), but Suv39H1/H2 knockdown eliminated peripheral targeting to background levels 
(Fig. 3.9b). 
 
Discussion: 
Two independent peripheral targeting mechanisms active in different but adjacent 
sequences: 
 Large-scale chromatin folding complicates identification of cis and trans elements 
targeting chromosome regions to particular nuclear compartments. Active targeting via a 
single sequence will cause apparent targeting of 100s-1000s of kb of adjacent 
chromosomal sequence, as visualized by conventional light microscopy. Conversely, 
additional targeting mechanisms distributed across this same 100s-1000s of kb of 
adjacent chromosomal sequence will mask the contributions of individual targeting 
mechanisms. 
 Here we used autonomous targeting of randomly integrated BAC transgenes to 
overcome these problems.  Using deletion analysis of a 207 kb HBB BAC, we correlated 
targeting to the nuclear periphery with elevated levels of H3K9me3 over these BAC 
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transgenes.  We next showed that this peripheral targeting was largely eliminated by 
Suv39H1/H2 knockdown.  Because Suv39H1/H2 knockdown had no effect on the 
peripheral localization of the endogenous HBB locus, we hypothesized a second targeting 
mechanism acting on flanking sequences.   
 Double knockdown of G9a and Suv39H1/H2 led to a significant displacement of 
the endogenous HBB locus away from the periphery.  Subsequent FISH analysis 
suggested a model in which the several hundred kb HBB region is tethered to the 
periphery through a Suv39H1/H2, H3K9me3 dependent mechanism, most of an adjacent, 
~1 Mbp LAD is tethered through a G9a, H3K9me2 mechanism, while a third, unknown 
mechanism tethers the distal LAD region to the periphery (Fig. 3.10a).  These three 
tethering mechanisms prevent significant displacement of either the LAD or the HBB 
regions after single knockdown of either H3K9me2 or H3K9me3.  Support for this model 
comes from the G9a dependent peripheral targeting of a second BAC transgene 
containing sequence from this adjacent LAD.  
 
Identification of PTRs and an epigenetic basis for peripheral targeting: 
 Focusing on the HBB BAC, an unbiased deletion analysis identified three 
Peripheral Targeting Regions (PTRs), each of which was sufficient to target the 
remaining ~100 kb HBB region to the nuclear periphery.  Nested deletions narrowed one 
of these, PTR1, to 6.3 kb.  Through this deletion analysis, a tight correlation was 
demonstrated between peripheral targeting and increased H3K9me3 immunostaining over 
the BAC transgenes.  ChIP against H3K9me3 demonstrated elevated levels over PTR1 
itself, plus a PTR-mediated general increase of H3K9me3 over the entire BAC transgene, 
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consistent with our immunofluorescence results.  Peripheral targeting activity was subject 
to position effects and inhibition of peripheral targeting was again correlated with loss of 
H3K9me3, either as an elevated peak over PTR1 in plasmid transgenes, or as reduced 
spreading of H3K9me3 over the HBB BAC transgene co-integrated with the DHFR 
BAC. 
 In the Introduction, we outlined several models for peripheral targeting.  Our 
results showing PCH targeting of the HBB BAC with all PTRs deleted and interior 
localization of two BACs containing intergenic regions contradict Model 1- default 
peripheral targeting of transcriptionally inactive chromosome regions.  Instead, our 
results strongly support Model 3- binding of particular epigenetic marks to components 
of the nuclear periphery.  In particular, our demonstration that the same PTR1 element 
which retargets the HBBD4 BAC from the PCH to the periphery instead targets the 
RP11-2I1 BAC from the interior to the PCH, strongly supports this epigenetic model, 
while contradicting Model 2 in which targeting is through the binding of specific DNA 
sequences, and/or the proteins binding to these sequences, to proteins at the nuclear 
periphery.  
 
A competition between targeting to two different heterochromatin compartments: 
 Our HBB BAC deletion analysis revealed an apparent competition between 
targeting to the PCH versus the nuclear periphery; this competition is intriguing in light 
of the known differential targeting of the endogenous locus to either the nuclear 
periphery or the PCH in different cell types.   
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 In particular, the sum of peripheral or PCH targeting for a specific cell clone was 
near constant, despite consistent differences in the ratio of peripheral versus PCH 
targeting between the full-length HBB BAC and different HBB BAC derivatives.  The 
PTRs bias this competition towards peripheral versus PCH targeting, rather than targeting 
to the periphery per se. 
 While the molecular mechanism for this competition remains unproven, we 
propose a working model (Fig. 3.10b-g) in which the quantitative levels of specific 
epigenetic marks averaged over sufficiently large chromatin domain determines targeting 
of genomic loci to the nuclear periphery versus the PCH or nuclear interior.  H3K9me3 
marked chromatin is enriched near the nuclear periphery but also present throughout the 
nuclear interior.  Therefore we suggest H3K9me3 is one of these marks and is necessary 
but not sufficient for targeting; however, we cannot rule out Suv39H1/H2 mediated 
methylation of a different substrate as the cause of targeting. PTR nucleation and/or the 
global spreading of these heterochromatin marks is modulated by the epigenetic state of 
flanking DNA sequences, with the ultimate targeting decision determined by the level of 
epigenetic modifications over the chromatin domain.   
 At the endogenous locus, it is likely that changes in the Suv39H1/H2 independent 
targeting activity of flanking regions would also have to occur to redirect the HBB locus 
away from the periphery to the PCH. 
 
Relationship to other studies:   
 Using a similar autonomous BAC targeting approach, peripheral targeting of the 
transcriptionally inactive IgH and Cyp3a multi-gene loci recently was shown to involve 
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binding of GAGA factor cKrox to GA motif clusters (43).  It is unclear how prevalent 
these GA motif clusters are within the genome.  None are present in the HBB BAC, and 
only two are located within 2 Mbp surrounding the HBB endogenous locus.  Neither 
significantly contributes to peripheral targeting of this chromosome region. 
 In contrast, recent findings in C.elegans identified two H3K9 histone 
methyltransferases (HMTs) as required for anchoring multi-copy gene arrays.  RNAi 
knockdown of both HMTs resulted in reduced lamin interactions of chromosome arm 
regions and selected gene loci enriched in H3K9me3 in wild type embryos (Towbin et al., 
2012).  The functional redundancy for these two HMTs, only one of which is able to 
trimethylate H3K9, suggested a single peripheral targeting mechanism in C. elegans 
embryos.    
 In mammalian cells, knockdown of G9a, a HMT responsible for roughly 50% of 
total nuclear H3K9me2 (28) and most of the H3K9me2 enriched at the nuclear periphery, 
reduces LAD targeting to the periphery approximately two fold based on biochemical 
assays (20).  However, G9a knockdown failed to change the peripheral localization of 
late replicating, G9a regulated genes based on cytological assays (40). 
 Our results blend aspects of several of these studies:  we demonstrate dependence 
of peripheral targeting through G9a induced H3K9me2 and Suv39H1/H2 induced 
H3K9me3 but these pathways act on different genomic regions separated by hundreds of 
kb.  Apparent functional redundancy is suggested by cytological assays, due to the 
tethering activity of neighboring chromosome regions, but BAC transgenes allow a clear 
separation of H3Kme2 and H3K9me3 related pathways.  
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Future Directions: 
 Our results reveal two independent pathways for peripheral targeting, each of 
which can be recapitulated by BAC transgenes that autonomously target to the periphery 
through a dependence on a single pathway.  Focusing on the HBB BAC, we demonstrate 
the feasibility of using BAC transgenes to identify cis elements that confer peripheral 
targeting and ultimately dissect the molecular mechanisms involved.   
 A current paradox in considering the functional consequences of targeting gene 
loci to "repressive" nuclear compartments is that only a fraction of alleles, for instance 
~50% for the beta-globin locus, show this targeting.  Importantly, the fraction of cells 
with elevated H3K9me3 over the HBB BAC transgenes was significantly higher than the 
percentage of peripherally located transgenes.  These PTRs from the HBB BAC may 
better be described as elements that confer a particular heterochromatin state that includes 
spreading of H3K9me3 over a large domain in most cells, resulting in targeting to the 
PCH and peripheral nuclear compartments in a fraction of these cells. Future dissection 
of the molecular mechanisms underlying PTR action may therefore reveal how specific 
sequences establish distinct epigenetic states over large chromatin domains.   
 Such dissection should allow us to distinguish functional consequences of 
differential nuclear targeting per se from the functional consequences of establishing 
distinct epigenetic states. 
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Materials and Methods: 
BAC constructs, Transposon Insertions, and Recombineering: 
 Human BACs CTD-2643I7, CTD-2207K13, RP11-344L6, RP11-2I1, CTD-
2547L21, RP11-715G8, RP11-76C5, RP11-678B18 and RP11-982G19 were obtained 
from Invitrogen.  DHFR BAC 057L22 (CITB mouse library) was a gift from Edith Heard 
(Curie Institute).  Tn5 transposon insertion into BAC DNA was done using the 
EZ::TN5TM kit (Epicentre Technologies) following the manufacturer’s directions.  DNA 
sequencing from both ends of the transposon mapped transposon insertion sites.  A Tn5 
transposon carrying the 256mer lac operator direct repeat and kanamycin/neomycin 
selectable marker was excised from p[K/N-PSI-8.32] (33) and transposed into CTD-
26417, inserting 55 kb 5' from HBB to generate CTD-26417-K/NPSI8.32.  Similarly, 
p[K/N-PSI-8.32] was transposed into RP11-715G8 to generate RP11-715G8-
K/NPSI8.32.  A Tn5 transposon carrying the 256mer lac operator repeat and a kanamycin 
selectable marker was excised from p[Kan-8.32] (19) and transposed into BAC 057L22, 
inserting 75 kb 3' to the Msh3 transcription initiation site to generate 057L22-K-8.32-
C29; a second Tn5 transposon carrying a CMV-mRFP reporter gene and a Zeocin 
selectable marker was excised from pCRZ (5) and transposed into 057L22-K-8.32-C29 
inserting at nucleotide 23,426 of the Msh3 gene generating  057L22-K-8.32-C29-C27.   
 Two Tn5 transposons carrying the 6.3 kb PTR1 sequence were made:  
p[Kan/Neo-8.32] (19) was linearized with SalI and ligated with a 6.3 kb PTR1 region 
fragment, generated by PCR amplification using the CTD-2643I7 BAC as substrate with 
primers ATCCTCTAGAGTCGACTCTGGAGGCCAAGTGTCTCT and 
CGCCTCTAGAGTCGACCATGTCCTTTGCCCACTTTT, and then cut with SalI, 
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generating p[Kan/Neo-HBB6kb-8.32].  p[Zeo] (5) was digested with SalI and ligated 
with the 6.3 kb fragment excised by SalI digestion of p[Kan/Neo-HBB6kb-8.32] to 
generate p[Zeo-HBB6kb]. 
p[Kan/Neo-HBB6kb-8.32] was used to generate a Tn5 transposon carrying the 
256mer lac operator direct repeat, 6.3 kb PTR1 and kanamycin/neomycin selectable 
marker, which was transposed into BACs CTD-2207K13 and RP11-2I1 to generate 2I1 
HBB 6kb lacO-C3 and 2207 HBB 6kb lacO-C2 respectively.  p[Kan/Neo-8.32] was used 
to generate a Tn5 transposon carrying the 256mer lac operator repeat and a 
kanamycin/neomycin  selectable marker, which was transposed into BACs CTD 
2207K13 and RP11-2I1 to generate 2I1-lacO-C1and 2207 lacO-C2 respectively.  p[Zeo-
HBB6kb] was used to generate a Tn5 transposon carrying the 6.3 kb PTR1 and Zeocin 
selectable marker and transposed into HBBD4 BAC to generate the HBBD4-6kb-C5, 
which  has the transposon inserted 28kb downstream of HBE1. 
 
BAC Deletions using BAC Recombineering:  
 λ red-mediated BAC recombineering using a galK-based dual selection scheme 
was used to delete specific regions from beta-globin BAC CTD-26417-K/NPSI8.32-C4. 
Sequential rounds of recombination mediated deletion with galK insertion followed by 
galK removal using standard recombineering protocols (3) allowed generation of BAC 
derivatives with more than one deleted region.  CTD-26417-K/NPSI8.32-C4 was 
transformed into E.coli strain SW102 in which the λ red recombination machinery is 
induced by shifting temperature from 32 to 42˚C (38).  Recombination DNA fragments 
with homology ends were prepared by PCR using primers (Table B.1) with 43 bp 
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homology sequences plus 17 bp sequences (forward 5’-cgacggccagtgaattg-3’, reverse 5’-
tgcttccggctcgtatg-3’) for amplifying the galK selectable marker from plasmid pGalK.  
Following galK insertion, recombinants were selected at 32˚C on minimal medium in 
which galactose was supplied as the only carbon source. Recombinants were screened by 
PCR using 20bp primers outside of the target regions.  Subsequent removal of galK used 
DNA fragments generated by PCR using partially overlapping 60bp primers (GkRm-F 
and –R, Table B.1).  Each of the 60bp primers consisted of a 52bp homology region 
flanking the galK marker and an 8 bp sequence complementary to the last 8 bp of the 
opposite homology region.  Negative selection used minimal medium containing 2-
deoxy-galactose (DOG) and deletion of galK in recombinants was verified using 
CHECK-F and –R primers (Table B.1). Integrity of BAC constructs and the lac operator 
repeat length was verified by restriction fingerprinting using an AvaI and HindIII double 
digest.   
 
Sequence Analysis:  
 Searching for GA motifs, as described in LAS (43), in PTRs, the HBB locus, and 
DNA flanking the HBB locus was done using the MEME software package (2). 
 
Cell culture and establishment of BAC cell lines: 
 NIH 3T3 cells (CRL-1658, ATCC) were grown in Dulbecco modified Eagle’s 
medium (Invitrogen) plus 10% Bovine Growth Serum (HyClone) at 37 oC with 5% CO2. 
All transfections were performed using LipofectamineTM 2000 (Invitrogen). Stable cell 
lines were selected and subcloned as described previously (34). To create NIH 3T3 cell 
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clone 3T3_LG_C29 stably expressing EGFP-dimer lac repressor-NLS fusion protein, the 
plasmid p3’SS-eGFP-dlacI (31) was linearized by XmnI and transfected into 3T3 cells.  
Stable selection used 200 µg/ml Hygromycin B (Calbiochem).   
 BAC DNA was purified using the Qiagen large-construct kit.  Purified BAC DNA 
was linearized, ethanol-precipitated, and transfected into 3T3_LG_C29 cells, followed by 
selection of stable transformants using 800 µg/ml G418 and 200 µg/ml Hygromycin- B. 
For beta-globin and DHFR BAC co-transfection, both BACs were linearized with PI-SceI 
and BsiWI, respectively, and transfected into 3T3_LG_C29 as described above using 800 
µg/ml G418, 200 µg/ml Hygromycin B and 75 µg/ml Zeocin for selection. 
BACs CTD-2207K13 and RP11-2I1 were digested with PvuI and AscI, 
respectively, before transfection into 3T3_LG_C29 cells and selection of stable clones 
with 600 µg/ml G418 and 200 µg/ml Hygromycin B.  BAC HBBD4-6kb-C5 was 
linearized with PI-SceI before transfection into 3T3_LG_C29 cells and stable clones 
were selected with 600µg/ml G418, 200µg/ml Hygromycin B, and 75µg/ml Zeocin. 
Plasmid p[Kan/Neo-HBB6kb-8.32] was linearized with PvuI before transfection into 
3T3_LG_C29 cells and stable clones were selected with 800µg/ml G418 and 200µg/ml 
Hygromycin B. 
 The full names for 3T3 cell clones in Fig. 3.4b were HBBD4_C40.5, C40.10, and 
C40.22 (versus HBBD4-5, 10, or 22).  For H3K9me3 immunostaining comparisons we 
used the following cell clones (Fig. 3.5):  HBB_C3, HBBD5_C43, HBBD10_C32, 
HBBD5D8_C35, HBBD4_C29.7, D4_C40.10, D4_C40.5, HBBD5D7_C29.17, 
D5D7_C29.22, HBBD5D7_C40.15, HBBD4-PTR1_B6, and DHFR_HBB_2.12. 
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BJ-hTERT cells were obtained as a gift from Dr. Peter Adams (Beatson Institute/ 
Glasgow University) and grown in DMEM supplemented with 10% FBS, MEM 
nonessential amino acids, vitamins and 0.54 µg/ml Puromycin at 37 oC with 5% CO2. 
WI-38 cells (ATCC) and Tig3ET cells (a gift from Dr. Bas Van Steensel, Netherlands 
Cancer Institute) were grown in DMEM plus 10% Fetal Bovine Serum (Sigma-Aldrich) 
at 37 oC with 5% CO2. 
 
Immunostaining, Western Blots, DNA-FISH and Immuno-FISH: 
 NIH 3T3 cells were fixed with 3% paraformaldehyde (freshly prepared from 
powder) in CMF-PBS (Calcium Magnesium Free PBS) for 10 min at room temperature 
and washed 3x with CMF-PBS.  Cells were then permeabilized with 0.5% Triton X-100 
(Pierce) in CMF-PBS for 5 min at room temperature and blocked with 5% normal goat 
serum for 30 min.  Primary antibody was applied for 4 hrs at room temperature or 
overnight at 4°C in CMF-PBS containing 0.1% Triton X-100 at the following dilutions: 
mouse monoclonal antibody RL1 against nuclear pore O-linked glycoprotein, 1:500 
(ABR-Affinity BioReagents); anti–lamin A antibody, 1:500 (obtained from B. Goldman, 
Northwestern University, Evanston, IL); anti-H3K9me2 (Abcam ab1220 or Millipore 07-
441) 1:500 ; and rabbit anti-H3K9me3 (Abcam ab8898 or Upstate 07-442), 1:500.  Cells 
were washed with CMF-PBS 3x for 5 mins and stained with secondary goat anti-rabbit or 
anti-mouse antibody conjugated with Texas red (Jackson ImmunoResearch Laboratories) 
at 1:500 dilution overnight at 4°C.  Cells were washed with CMF-PBS 3x for 5 mins and 
mounted in antifade medium containing 0.3 µg/ml DAPI (Sigma-Aldrich)/10% wt/vol 
Mowiol 4–88 (EMD)/1% wt/vol DABCO (Sigma-Aldrich)/25% glycerol/0.1 M Tris, pH 
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8.5. Western blotting used 1:100 dilution of mouse anti-cKrox (Santa Cruz 
Biotechnology, sc-376250) or 1:1000 dilution of anti-H3K9 dimethylation antibodies 
(Abcam ab1220). 
Anti-lamin A or H3K9me3  immunstaining prior to DNA FISH used a similar 
procedure as described above with a 1:1000 dilution of anti-lamin A or 1:500 dilution of 
anti-H3K9me3 primary antibody. Following secondary antibody staining, cells were 
postfixed in 3% paraformaldehyde in CMF-PBS for 10 min at room temperature and 
washed in 0.1M HCl / 0.7% Triton X-100 (Pierce) in 2xSSC for 10 min on ice.   
DNA FISH was performed as described previously (Hu et al., 2009).  Briefly, 
paraformaldehyde fixed cells were permeabilized in 0.5% Triton-X-100. Cells were 
subjected to four freeze thaw cycles before storing in 50% formamide/2XSSC. FISH 
probes were prepared using nick-translation of BAC DNA (BioNick Labeling System, 
Invitrogen) using biotin and/or digoxigenin (DIG) labeled nucleotides. Probes and cells 
were co-denatured on a 750C heat block for 2min followed by overnight hybridization at 
370C, followed by washes in 0.4X SSC at 700C for 2min and 2XSSC. Detection used 
Streptavidin-Alexa594 (Invitrogen) and/or anti-DIG-fluorescein antibodies (Roche). 
 
Knockdown Experiments: 
For Suv39H1, Suv39H2, and G9a knockdowns, MISSION shRNA lentiviral 
transduction particles (Sigma-Aldrich) were used according to the manufacturer’s 
protocol.  Briefly, lentiviruses coding for shRNA for mouse Suv39H1 (NMID: 
NM_011514, Clone ID: TRCN0000097440), mouse Suv39H2 (NMID: NM_022724, 
Clone ID: TRCN0000092815) and mouse G9a (NMID: NM_145830, Clone ID: 
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TRCN0000054543) or human Suv39H1 (NMID: NM_003173.2-861s21c1, Clone ID: 
TRCN0000275322) and human Suv39H2 (NMID: NM_024670.3-629s1c1, Clone ID: 
TRCN0000006938) were used at ~3 x 104 TU each to infect ~1 x 104 NIH 3T3 (mouse) 
or WI38 cells (human) overnight in the presence of 6 µg/ml polybrene at 37°C. 
Scrambled shRNA was used as control. Media was changed the next day followed by 
puromycin (2 µg/ml) selection 2 days after transduction.  Selection media was changed 
every 3 days; 7 days of selection, cells fixed with 3% paraformaldehyde were used for 
immunostaining or immuno-FISH. 
Depletion of human cKrox, Suv39H1, and Suv39H2 were performed using 
siGENOME siRNA -SMARTpool (Dharmacon, Thermo Scientific). Tig3ET cells were 
transfected with siRNA using Lipofectamine (Invitrogen) following the manufacturer’s 
protocol and were cultured for 48 hrs before being used for analysis. 
For the G9a inhibition, Tig3ET or NIH-3T3 cells were treated with BIX01294 
(Kubicek et al., 2007) or UNC0638 (Vedadi et al., 2011)  (both from Sigma-Aldrich) for 
2 days, at a final concentration of 1 µM or 500 nM, respectively. 
Knockdown experiments were performed in at least 2 biological replicates and a 
pooled result is displayed. 
 
Microscopy, image analysis, and statistical analysis: 
 A Personal Deltavision deconvolution microscope system (Applied Precision) 
equipped with a CoolSnap HQ2 CCD camera was used with a 60×, 1.4 NA lens for data 
collection.  Deconvolution used an enhanced ratio, iterative constrained algorithm, using 
the Applied Precision SoftWorx software.  2D distances between GFP-Lac repressor 
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spots and the nuclear edge defined by DAPI staining were measured from the optical 
section in which the GFP-Lac repressor spot was in focus using ImageJ (National 
Institutes of Health) software.  Image segmentation of the DAPI stained nucleus was then 
performed using the OtsuThresholding 16Bit and k-mean clustering plugins with the 
following parameters: number=2, cluster=0.00010000 and randomization=48.  For BAC 
transgenes consisting of multiple GFP-Lac repressor spots, measurements were taken 
from the spot closest to the nuclear edge.  P-values were calculated from two-tailed, two 
sample unequal variance t-tests.  Adobe Photoshop and Illustrator programs were used to 
assemble microscopy images with bicubic interpolation used to rotate or enlarge images.  
 
 
RT-qPCR: 
Total RNA was extracted from NIH 3T3 cells using the RNeasy Mini Kit 
(Qiagen), with on column DNase I digestion (NEB) according to the manufacturer's 
instructions. cDNA was synthesized from 1 µg total RNA with the qScript™ flex cDNA 
kit (Quanta Biosciences). Quantitative real-time PCR was performed on an Applied 
Biosystems Step One Plus instrument using a 2X SYBR Green mix. Real-time PCR 
reactions were performed in triplicate. β-actin was used as a reference to obtain the 
relative fold change for target samples using the comparative Ct 2(-ddct) method.  
 
Chromatin Immunoprecipitation (ChIP):  
 ChIP was performed on NIH-3T3 cell clones containing specific HBB BAC or 
plasmid transgenes. 10 million cells were cross-linked by adding paraformaldehyde 
(Polysciences, 16% EM grade) directly to the culture medium to a final concentration of 
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1% at RT for 10 min. Cross-linking was stopped by adding glycine to a final 
concentration of 0.125 M for 5 min at RT, followed by addition of ice-cold PBS.  Cells 
were trypsinized, centrifuged, and washed 3x 10 min with PBS at 4°C.  Cells were lysed 
on ice for 30 min in L1 buffer (50 mM Tris at pH 8.0, 2 mM EDTA, 0.5% Nonidet P-40 
(NP-40), 10% glycerol) supplemented with protease inhibitor cocktail (Roche). Nuclei 
were pelleted at 700 g and resuspended in SDS lysis buffer (50 mM Tris at pH 8.0, 5mM 
EDTA, and 1% SDS) supplemented with protease inhibitors. Chromatin was sheared by 
sonication (Bioruptor UCD-200TM, Diagenode), centrifuged to pellet debris and diluted 
10x in ChIP dilution buffer (16.7mM Tris-HCl at pH 8.0, 1.1% Triton-X-100, 167 mM 
NaCl, 0.01% SDS, and 1.2 mM EDTA). Extracts were incubated for 1 hr at 4°C with 75 
µl of Dynabeads Protein G (Invitrogen) blocked with salmon sperm DNA and BSA, 
followed by the removal of beads. 5% of the supernatant was saved as an input control.  
ChIP samples were then incubated with either 10µg of H3K9me3 antibody (Abcam- 
ab8898) or non-specific IgG (Jackson Immunoresearch Laboratories) and incubated at 
4°C overnight with rotation. 
Immunoprecipitations were carried out with 100 µl of Dynabeads Protein G 
blocked with Salmon sperm DNA and BSA for 1hr at 4 °C. Immune complexes were 
then washed with low salt buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 mM 
Tris-HCl, pH 8.1, and 150mM NaCl), followed by high salt wash buffer (0.1% SDS, 1% 
Triton X-100, 2mM EDTA, 20 mM Tris-HCl, pH 8.1, and 500mM NaCl), followed by 
LiCl wash buffer (0.25M LiCl, 1% NP40, 1% deoxycholate, 1 mM EDTA, and 10 mM 
Tris-HCl pH8.0) (5 min each at 4 °C). Immune complexes were further washed 2 times 
with TE buffer before eluting with the ChIP elution buffer (1% SDS, 0.1M NaHCO3). 
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  DNA crosslinks were reversed by addition of 0.2 M NaCl and incubation at 65 °C 
overnight. Proteins and RNA was removed by proteinase K (50 µg/ml, 1hr at 45°C) and 
RNase A treatment (20 µg/ml, 30min at 37°C) and DNA purified with Qiagen spin 
columns. Primers for qPCR are listed in Table B.2.   
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Figures: 
 
Figure 3.1. 200kb human beta-globin BAC transgene targets to nuclear periphery 
similarly to endogenous beta-globin locus.   
 
 
 
(A- C) FISH shows peripheral localization of endogenous beta-globin locus in human BJ-
hTERT (A) and mouse NIH 3T3 (B) fibroblasts but interior localization for the alpha-
globin locus in mouse NIH 3T3 cells (C) (DAPI (blue), FISH (green), Lamin-A 
immunostaining (red)).  (D-F) Peripheral localization of HBB BAC identified by EGFP-
lac repressor binding (green) in HBB C3 NIH 3T3 cell clone using DAPI staining (blue) 
(D), Lamin A immunostaining (red) (E), or nuclear pore staining (red) (F) to define the 
nuclear periphery. (G) Fraction of cells with peripheral localization in each 3T3 subclone 
for HBB (black) or DHFR (green) BAC transgenes as compared to endogenous beta-
globin loci (HBB) in human BJ-hTERT (dark grey) or mouse NIH 3T3 (red) cells or 
alpha-globin loci (HBA) in human BJ-hTERT cells.  HBB BAC (no LacO) (yellow) 
refers to FISH measurements from mixed population of stable 3T3 clones with HBB 
BAC with just a selectable marker but no lac operator repeat inserted.  "Random" shows 
fraction of DAPI staining within 0.5 µm from the periphery.  ≥50 cells from each BAC 
transgene NIH 3T3 cell clone and ≥45 cells for each endogenous gene FISH experiment 
were analyzed.  Scale bars= 2µm. 
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Figure 3.2.  Sequence dissection of beta-globin BAC reveals three peripheral 
targeting regions (PTRs). 
   
 
 
(A) Map of ~200kb human beta-globin BAC aligned with the Lamin B1 DamID (human 
fibroblast Tig3 cells), DNase1 hypersensitivity (normal human lung fibroblasts- NHLF), 
and CTCF binding (NHLF) maps from UCSC Genome Browser.  Red lines indicate  
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Figure 3.2. Cont. 
 
specific deletions made. (B-D, F-G) Statistics for BAC transgene peripheral localization 
in independent NIH 3T3 subclones.   (B) The LCR (D1), beta-globin gene cluster (D2), 
and entire 116 kb region encompassing the beta-globin locus, including the UHR and 3' 
HS1, all are dispensable for peripheral localization.  (C) Loss of peripheral targeting by 
the D5D7 double deletion, a control containing mostly BAC vector backbone and Tn5 
transposon sequence, and the D4 deletion suggests specific cis elements outside the beta-
globin locus are required for targeting.  (D) At least two functionally redundant regions 
within the D4 region are sufficient for peripheral targeting since D8, D9, D10, and double 
deletions D5D8 and D5D10 BACs display similar peripheral targeting.  (E-G) Further 
sequence dissection reveals at least three PTRs sufficient for peripheral targeting.  (E) 
Additional deletions relative to PTR locations (red bars) as shown for ~80 kb of 3' end of 
BAC. (F) Nested set of deletions reveals 6.3 kb PTR1 by loss of peripheral targeting in 
D8D14 deletion and persistence of peripheral targeting in D8D13D22 triple deletion, 
PTR2 by persistence of peripheral targeting in D8D17 double deletion, and PTR3 by D8 
deletion.  (G) Summary of sequence dissection showing median peripheral targeting 
levels for five cell clones analyzed for each BAC shown.  Distances between BAC 
transgenes and nuclear periphery were measured in at least 50 cells for each cell clone.  
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Figure 3.3.  Competition between nuclear peripheral versus chromocenter targeting.   
 
 
(A) D4 and D8D14 BAC transgenes exhibit significantly higher percentages of 
chromocenter association compared with intact (HBB) or D5 deletion (HBBD5) beta-
globin BAC transgenes. (B) Representative cells from three independent cell clones 
showing association of HBBD4 transgenes (green) with chromocenters.  DNA DAPI 
staining (blue).  Scale bars= 2µm.  (C) Stacked bar plots show a near constant sum of 
peripheral (grey) or chromocenter (black) transgene targeting for multiple, independent 
cell clones carrying HBB, HBBD4, or HBBD5 transgenes, or a mixed population of 
stably selected cell clones for HBB BAC transgenes not containing LacO repeats, 
suggesting competition between targeting to the nuclear periphery versus chromocenter.  
(a,c)  Localization of BAC transgenes to either nuclear periphery or chromocenter was 
measured in at least 50 cells for each cell clone.  (D-E) Quantitative real-time PCR 
analysis of relative mRNA expression levels, normalized by copy number, for beta-
globin (HBB), olfactory receptor (OR), and selectable marker (KN) genes in cell clones 
containing either HBB BAC or HBBD4 BAC.  Expression per gene copy was normalized 
relative to the expression in the cell clone containing HBB BAC (D) or the expression of 
the endogenous mouse HBB gene (E).  Data shows mean + SEM from 3 independent 
experiments.    
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Figure 3.4.  Peripheral targeting activity of PTRs is context specific.   
 
Histograms showing targeting frequency to nuclear periphery versus chromocenter for 5 
independent clones containing different plasmid or BAC constructs.  (A) PTR1 does not 
confer targeting to the nuclear periphery when placed in a plasmid containing a 256mer 
lac operator (LacO) repeat.  Top- plasmid maps with vector backbone (grey), PTR1 (red), 
and Kan/Neo selectable marker (yellow). (B) Co-integrated DHFR and beta-globin BACs 
(DHFR_HBB) target with high frequency to chromocenter rather than the peripheral 
targeting seen for HBB BACs alone.  Map of ~180kb DHFR BAC- LacO (green), Zeocin 
selectable marker (red).  (C) Examples of chromocenter association for several         
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Figure 3.4. Cont. 
 
independent clones with varying size, co-integrated DHFR/HBB BAC transgene arrays 
LacO staining (green), DAPI DNA staining (blue). Scale bar = 2µm.  (D) Insertion of the 
6.3kb PTR1 to HBBD4 BAC by transposon restores peripheral targeting.  Top- map 
showing PTR containing transposon (red arrowhead).  (E-F) Whereas insertion of PTR1 
into BAC CTD-2207K13 changes neither peripheral nor chromocenter targeting (E), 
PTR1 insertion into BAC RP11-2I1 significantly increases chromocenter, but not 
peripheral targeting.  Localization of BAC transgenes to either nuclear periphery or 
chromocenter was measured in at least 50 cells for each cell clone.  
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Figure 3.5.  Differential targeting to the nuclear periphery versus chromocenter 
correlates with H3K9me3 levels over BAC transgenes.   
 
 
(A-F) BAC transgene locations (green, EGFP-lac repressor staining), H3K9me3 
immunostaining (red), DAPI (blue)- enlarged insets show regions at 2X magnification 
with red arrowheads in red channel (middle) pointing to location of transgenes in green 
(top) channel.  (A-C) HBB BAC transgene locations in clone HBB-C3 overlap with 
H3K9me3 immunostaining foci regardless of whether transgenes are located at nuclear 
periphery (A), chromocenter (B), or interior (C). (D-F) Examples from clone HBB C3 
showing “strong” (D), “weak” (E), or “no” (F) H3K9me3 signals over the BAC 
transgenes.  (G) Strength of H3K9me3 immunostaining over different BAC transgenes 
(left) correlates with differential targeting of BAC transgenes (right) to nuclear periphery 
(black) versus chromocenter (grey).  Scale bars=2µm, insets are at 2x magnification.  
Data shown for each BAC is pooled from at least 2 independent experiments. 
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Figure 3.6.  ChIP-qPCR measurements of context specific H3K9me3 modifications 
over PTR1 and HBB BAC transgenes.    
 
 
 
 
(A) Map of HBB BAC with location of primers used for ChIP-qPCR: primer spacing was 
~1 kb over PTR1 but ~5 kb elsewhere.  (B-D) ChIP-qPCR measurements of H3K9me3 
levels with %input values normalized by scaling linearly between "0" (GAPDH  
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Figure 3.6. Cont. 
 
promoter) and "1" (IAP transposon) (see text).  (B) Three biological replicates (A,B,C) 
show reproducibility of H3K9me3 ChIP over HBB BAC with consistent peak over  
PTR1.  (C) H3K9m3 ChIP values of full length HBB BAC (green) versus HBBD4 BAC 
deleted of all PTRs(red) or HBBD4 BAC with PTR1 reinserted at arrow location (blue,  
inset shows PTR1 values with actual orientation).  (D) H3K9me3 ChIP values for HBB 
BAC by itself (red) or intact HBB BAC flanked by transcriptionally active DHFR BAC 
transgenes (blue).  (E) Mean H3K9me3 ChIP levels are lower for HBBD4 relative to 
HBB or HBBD4+PTR1 BACs.  (F) Mean H3K9me3 immunofluorescence (IF) levels are 
similarly reduced for HBBD4 versus HBB transgenes using a normalized, linear scaling 
of IF values between DAPI regions with low IF ("0") and chromocenter IF ("1") (see 
text).  (G) Normalized mean H3K9me3 ChIP values are decreased over PTR1 in plasmid 
transgenes relative to HBB, HBBD4 + PTR1, or HBB flanked by DHFR BAC 
transgenes. (H) Reduced H3K9me3 mean, normalized values for ~100 kb HBB region 
(primer pairs 2-18) without PTRs in HBBD4 BAC lacking PTRs but also in full length 
HBB BAC transgenes flanked by DHFR BACs. (E-H) Statistical significance: * p<0.05, 
**p<0.01 
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Figure 3.7.  Reducing H3K9 methylation inhibits beta-globin BAC targeting to 
periphery and chromocenter.   
 
 
(A-D) Reduced peripheral targeting of HBB clone C3 cells with increased reduction of 
H3K9me3: (A-C) Left panels: HBB C3 cells after combined Suv39H1 and Suv39H2 
shRNA knockdown showing normal level (A), reduced level (B), or no (C) H3K9me3 
staining (red).  (D) Statistics for peripheral targeting.  (e- h) Reduced association with 
chromocenter of HBBD4 BAC transgenes with increased reduction of H3K9me3:  (e-g) 
HBBD4 Clone C40.10 cells after combined Suv39H1 and Suv39H2 shRNAs knockdown 
showing normal (E), reduced (F) and no (G) H3K9me3 immunostaining (red).  (H) 
Statistics for chromocenter association.  (A-C, E-G) DAPI (blue), EGFP-LacI (green), 
arrowheads indicate BAC transgenes.  Middle panels- DAPI staining, right panels- 
H3K9me3 staining (red).  Scale bars=2µm.  Data shown is pooled from at least 3 
independent experiments. 
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Figure 3.8.  H3K9me3 and H3K9me2 double knockdown inhibits peripheral 
targeting of endogenous human beta-globin locus.  
 
 
 
(A) Schematic of ~2.5Mbp region showing human beta-globin locus and its flanking 
LAD regions (Lamin B1 DamID, human fibroblast Tig3 cells, hg19 assembly, UCSD 
Genome browser).  DNA FISH BAC probes shown below the map as black lines are 
labeled red for HBB, green for LAD sequences.  (B-E) Representative DNA FISH 
images showing classes of HBB (red) and adjacent LAD localization (green) (DAPI, 
grey):  (B) HBB and LAD both interior, (c,c’,c’’,c’’’) HBB and LAD both peripheral, (D 
and E) polarized orientation with HBB locus at periphery and LAD extended into interior 
(D) or LAD locus attached at one end to periphery but extended such that HBB is in 
interior (E). (F-I) statistics for these different localization classes (B-E). Suv39H 
(H3K9me3 KD) knockdown or G9a (H3K9me2 KD) inhibition did not change the 
localization of HBB; however, double knockdown of H3K9me3 and H3K9me2 
significantly reduces the preferential peripheral localization of HBB.  The polarized 
orientation (E,I) with the flanking LAD attached peripherally at its distal end suggests 
existence of a third tethering mechanism, independent of Suv39H and G9a (Fig. 10a).  
n>100, data shown is pooled from at least 3 independent experiments.  Scale bars= 2µm 
(insets magnified 2x), statistical significance: * p< 0.05.  
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Figure 3.9. Independent peripheral targeting mechanisms for HBB versus LAD 
BAC transgenes.   
 
 
(A) Schematic of HBB (CTD-2643I7) and LAD (RP11-715G8) BACs aligned relative to 
flanking LAD sequence (labeling as in Fig. 8).  (B) Peripheral targeting of HBB BAC 
transgene is inhibited after Suv39H knock down (me3 KD) but not G9a inhibition (me2 
KD).  (C) Peripheral targeting of RP11-715G8 BAC transgene is inhibited after G9a 
inhibition (me2 KD) but not after Suv39H (me3 KD).  Normal (D) or reduced (E) 
H3K9me3 immunostaining after scrambled (D) or combined Suv39H1 and Suv39H2 
shRNA (E). (F)  H3K9me2 Western Blot before (-) and after (+) BIX G9a inhibition 
(Tubulin loading control).  (B,C) n>50, data shown is pooled from at least 3 independent 
experiments.  Scale bars= 2µm, statistical significance: * p< 0.01. 
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Figure 3.10.  Working model for HBB locus nuclear targeting:   
 
(A) At least two independent peripheral targeting mechanisms act on adjacent sequences 
to anchor the HBB locus and surrounding sequences to periphery:  a Suv39H / H3K9me3 
dependent mechanism mediated by PTR sequences near HBB locus (red), a G9a / 
H3K9me2 dependent mechanism mediated by sequences in left flanking LAD region 
(green) (possibly also in right flanking LAD, dotted green), and a likely third, 
uncharacterized mechanism acting to tether distal LAD after combined Suv39H and G9a  
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Figure 3.10. Cont. 
 
knockdown/inhibition (dotted blue).  (B) Peripheral Targeting Regions (PTR) induce 
epigenetic modifications, leading to inhibition of gene expression and, in a fraction of 
cells, association with the nuclear periphery. Peripheral association may in turn reinforce 
gene repression.  (C) Nucleation of H3K9me3 by PTR and its propagation, presumably 
with other epigenetic marks, to flanking genomic regions. (D) Epigenetic modification(s) 
continuum depicted as white to black gradient with targeting to the nuclear interior 
(white), chromocenter (grey), or periphery (black) dependent on position within this 
continuum. (E) Cis elements establish epigenetic states characteristic for each BAC 
transgene resulting in differential nuclear targeting. (F) Addition of PTR1 shifts this 
continuum towards the "black", altering nuclear targeting. (G) Long-range influence of 
cis elements within DHFR BAC transgene shift epigenetic state of co-integrated HBB 
BAC transgenes from black (peripheral) to grey (chromocenter). (H) Reducing H3K9me3 
by Suv39H KD shifts epigenetic state towards "white".  
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CHAPTER 4 
Conclusions 
Association and disassociation of gene loci with respect to specific nuclear compartments 
accompany changes in gene expression, yet little is known concerning the mechanisms 
by which this occurs or its functional consequences. Previous work done in Belmont 
laboratory showed long-range motion of a peripheral chromosome site away from the 
nuclear periphery after artificial tethering of an acidic transcriptional activator, but the 
physiological relevance to natural gene activation was unknown. In Chapter 2, we have 
demonstrated long-range movements with nearly 4-fold higher velocity (1.14 versus 0.31 
µm/min) through activation of a transgene from a naturally occurring promoter sequence.  
Chromatin stretching in the direction of movement demonstrates a force generating 
mechanism.  Transcription in nearly all cases increased noticeably only after initial 
contact with a nuclear speckle.  Moreover, blocking new HSP70 transgene / speckle 
association by actin depolymerization prevented significant heat-shock induced 
transcriptional activation in transgenes not associated with speckles, although robust 
transcriptional activation was observed for HSP70 transgenes associated with nuclear 
speckles.    
There are two prevailing models for the function of nuclear speckles. They have 
been proposed to act either as hubs for a subset of transcriptionally active genes, or 
alternatively as storage sites for RNA processing component. Our results may bridge 
these two previous models for nuclear speckle function.  During heat shock we see 
evidence for both roles.  As with other conditions resulting in a general transcriptional 
inhibition, heat shock is accompanied by a reduced number and rounding of nuclear 
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speckles.  Yet, our results demonstrate a functional enhancement of HSP70 transgene 
transcription resulting from proximity with nuclear speckles through an as yet unknown 
mechanism.   
 Experiments are now in progress to examine the relationship between 
transcriptional induction and speckle proximity for BAC and endogenous HSP70 genes. 
We anticipate that our results and experimental system will facilitate future experiments 
aimed at elucidating the molecular mechanism underlying this movement and the 
transcriptional enhancement resulting from speckle association.  A significant fraction of 
endogenous genes associate with nuclear speckles when transcriptionally active; we 
speculate that similar active movements may play a role in the transcriptional regulation 
of those genes that change their nuclear localization upon transcriptional activation.  We 
also anticipate that the machinery enabling such long-range, active movements may be 
involved in multiple aspects of genome organization and nuclear architecture. 
 In Chapter 3, focusing on the HBB BAC, an unbiased deletion analysis identified 
three Peripheral Targeting Regions (PTRs), each of which was sufficient to target the 
remaining ~100 kb HBB region to the nuclear periphery.  Nested deletions narrowed one 
of these, PTR1, to 6.3 kb. Through this deletion analysis, a tight correlation was 
demonstrated between peripheral targeting and increased H3K9me3 immunostaining over 
the BAC transgenes. We next showed that this peripheral targeting of transgenes was 
largely eliminated by Suv39H1/H2 knockdown.  Because Suv39H1/H2 knockdown had 
no effect on the peripheral localization of the endogenous HBB locus, we hypothesized a 
second targeting mechanism acting on flanking sequences.  Double knockdown of G9a 
and Suv39H1/H2 led to a significant displacement of the endogenous HBB locus away 
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from the periphery.  Subsequent FISH analysis suggested a model in which the several 
hundred kb HBB region is tethered to the periphery through a Suv39H1/H2, H3K9me3 
dependent mechanism, most of an adjacent, ~1 Mbp LAD is tethered through a G9a, 
H3K9me2 mechanism, while a third, unknown mechanism tethers the distal LAD region 
to the periphery.  These three tethering mechanisms prevent significant displacement of 
either the LAD or the HBB regions after single knockdown of either H3K9me2 or 
H3K9me3.  Support for this model comes from the G9a dependent peripheral targeting of 
a second BAC transgene containing sequence from this adjacent LAD.    
 A current paradox in considering the functional consequences of targeting gene 
loci to "repressive" nuclear compartments is that only a fraction of alleles, for instance 
~50% for the beta-globin locus, show this targeting.  Importantly, the fraction of cells 
with elevated H3K9me3 over the HBB BAC transgenes was significantly higher than the 
percentage of peripherally located transgenes.  These PTRs from the HBB BAC may 
better be described as elements that confer a particular heterochromatin state that includes 
spreading of H3K9me3 over a large domain in most cells, resulting in targeting to the 
PCH and peripheral nuclear compartments in a fraction of these cells. Future dissection 
of the molecular mechanisms underlying PTR action may therefore reveal how specific 
sequences establish distinct epigenetic states over large chromatin domains.  Such 
dissection should allow us to distinguish functional consequences of differential nuclear 
targeting per se from the functional consequences of establishing distinct epigenetic 
states. 
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APPENDIX A 
Supplementary Data for Chapter 2 
Figures: 
 
Figure A.1. Trajectory step sizes exceed twice the radius of constraint after heat 
shock (HS).  
 
 
 
 
(A) Mean square displacement (MSD) versus time plotted for HSP70 transgenes at 37o C 
(blue, no HS) or 44o C (red, HS).  Inferred radius of constraint (square root of MSD 
plateau value) is ~0.15 µm.  Time sampling was every 2 sec.  (B-D) Histogram analysis 
shows that ~20% of Δd values, defined as the change in spot position between two 
consecutive time points, for HSP70 transgenes at 44o C (B), exceed the maximum Δd 
(0.3µm) for HSP70 transgenes at 37o C (C) or MT transgenes at 44o C (D).  Time 
sampling here was every 2 min.  Changes in position between adjacent time points, Δd, 
were measured from 2D projected images, after these projections were aligned to correct 
for nuclear translation and rotation occurring between time points. 
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Figure A.2. HSP70 BAC transgenes also show heat shock (HS) induced nuclear 
speckle association and long-range movements.  
 
 
 
(A) Schematic showing HSP70 BAC with 256-mer LacO repeat (red), Kan/Neo 
selectable marker (yellow), HSPA1B gene (blue), and a 24-mer MS2 repeat (magenta) 
inserted into the HSPA1B 3’UTR.  Scale bar = 10 kb.  (B-D) Live-cell imaging shows 
HSP70 BAC (red, mCherry-LacI) movement of BAC transgene to nearby nuclear speckle 
(green, EGFP-SON) (B), stretching of BAC transgenes followed by long-range 
movement to nearby nuclear speckle (C), and another example of long-range BAC 
transgene motion towards a nuclear speckle (D).  Time shown is minutes (‘) after HS.  
Insets show 2-fold enlarged views of transgene region. Scale bars= 2 µm. 
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Methods: 
DNA constructs:  
Plasmid pSP14-14-5’UTR-MS2, containing a 24mer MS2 repeat was obtained by 
ligating a 10kb fragment isolated from a partial BamHI digest of pSP14-14[1] to a 1.3kb 
fragment isolated from BamHI-BglII digested pSL-MS2-24[2].  mCherry was PCR 
amplified from pRSETB-mCherry[3] using primers 5’-
AAAAAAACCGGTCGCCACCATGGTGAGCAAGGGCGA GGA-3’ and 5’-
CAGAGGTGTACAGCTCGTCCATGC. This PCR fragment was digested with AgeI 
and BsrGI and ligated to AgeI-BsrGI digested CENPA-EGFP plasmid to generate the 
CENPA-mCherry plasmid. 
The Ubiquitin C (UBC) promoter was PCR amplified from BAC RP11-161A18 
(Invitrogen) using primers 5’ 
AAAAAAGGATCCCTTACAATAATCGTACCCATTGAAACCAG-3’ and 5’ 
AAAAAAGGTACCGTCTAACAAAAAAGCCAAAAACGGCC -3’, digested with 
BamHI and KpnI, and then ligated to the BglII-KpnI digested MS2bp-mCherry plasmid, 
thereby replacing the CMV promoter with the UBC promoter to create plasmid Ub-
MS2bp-mCherry. 
A Zeocin selection marker was inserted by λ Red-mediated BAC 
recombineering[4, 5] into the SON BAC (RP11-165J2, Invitrogen), creating the SON-
Zeo BAC.   Homology regions flanking the Zeo DNA fragment were added by PCR 
using the plasmid pSV40-Zeo (Invitrogen) as template with primers: 5’-
TCTGTCATGATGCCTGCAAGCGGTAACGAAAACG ATTTGAATATG 
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CCTCGATATCGCTAG-3’ and 5’-CCGCTCCACTTCAACGTAAC 
ACCGCACGAAGATTTCTATTGTTCCTGAGCAGGTCGACTC-3’.   
A second round of BAC recombineering added EGFP to the SON N-terminus in 
the SON-Zeo BAC, generating the EGFP-SON-Zeo BAC.  Plasmid pgalK-EGFP was 
generated by ligating BamHI-NotI digested pgalK[4] with BamHI-NotI digested pEGFP-
N1 (Clontech).  Using pgalK-EGFP as template, a galK-EGFP DNA fragment was 
generated by PCR, using primers 5’-GGGAGCCTGGAGGACTA 
GCGAGGAGGAGTTGA GAGAACGGAGCGGACGCCATGGTGAGCA-3’ and 5’-
ACCAGGATGGGCACCACCCCGGTGAACAGCTCCTCGCCCTTGCTCACCATGG 
CGTCCGCT-3’ to add homology regions for insertion of the galK-EGFP fragment. galK 
removal used the DNA fragment generated by PCR using partially overlapping primers: 
5’-GAGCCTGGAGGACTAGCGAGGAGGAGTTGAGAGAAC GGAGCGGACGCC 
CCTGTTGACAAT-3’ and 5’-GAATTTACTGACCACGAAAGA 
CCTAAAAATCTGCTCGATGTTGGTCGCCTTGTACAGCTC-3’.  
BAC 92G8+GK+REP_C22 containing a modified HSP70 locus in which 2 of the 
3 HSP70 homologous genes were deleted[1] was further modified, using λ Red BAC 
recombineering to insert a 24mer MS2 tag into the 3’UTR of the HSPA1B gene.  A 
three-homology box recombineering scheme was used to improve insertional 
efficiency.[5]  A targeting fragment 
(GTTTAAACCAGCTCTTTGCTGCTTCACTTCTTTGTAAAGTTAAGTTGTAACCTG
ATGGGGATCCGATATCTAATTAGCTGGCTTCATTATTTTTGTAGTACAACCGAT
ATGTTCATTAGAGAATTCATTCTTTGCATTTAATGTTGATACTGTAAGGGTGTT
TCGTTCCCTTTAAAGTTTAAAC) was synthesized with restriction sites BamHI/EcoRV 
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between homology boxes 1 and 2, EcoRI between boxes 2 and 3, and PmeI at both 
fragment ends and ligated into the pIDTSmart Kan vector (Integrated DNA Technology, 
Inc).  galK from pJET-galK was inserted into the fragment’s EcoR1 site and the 24X 
MS2 repeat into the BamHI/EcoRV site using BamHI/EcoRV digested pSL-MS2-24 to 
obtain the plasmid p-IDTSmart-MG. The fragment containing all 3 homology boxes, 
galK, and MS2 repeats was excised by PmeI digestion.  Initial attempts at insertion of 
this fragment into the HSP70 modified BAC resulted in deletion of the MS2 repeat due to 
recombination events involving homology boxes 2 and 3 rather than 1 and 3.  This 
problem was solved by inserting an additional 2.1 kb homology region into homology 
box 1.  A homologous DNA fragment was PCR amplified from HSP70 BAC using 
primers: 5’-CTTTCCAGAGCGAACCTGTG-3’ and 5’- 
AAAAAGGATCCATCAGGTTACAACTTAACTTTAC-3’; this PCR fragment was 
digested with BamHI and ligated into BamHI digested p-IDTSmart-MG to form p-
IDTSmart-BG.   Positive selection used minimal medium containing galactose as the 
only carbon source.  galK was then removed using a DNA fragment corresponding to 
homology boxes 2 and 3, amplified from the HSP70 BAC using primers 5’- 
AATTAGCTGGCTTCATTATTTTTG-3’ and 5’-GGTGGCAGTGTTGATTCATTT-3';  
negative selection was on minimal medium containing 2-deoxy-galactose, generating the 
92G8+3'MS2+GKREP_C26 modified HSPA1B BAC containing a 3’UTR MS2 tag. 
 
Cell culture and Establishment of Cell Lines: 
CHO DG44 cells were grown in F12 media (Invitrogen) supplemented with 10% 
Fetal Bovine Serum (Sigma), at 37°C with 5% CO2. All plasmids and BACs were 
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transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
directions.  The pSP14-14-5’UTR-MS2 plasmid was transfected into CHO DG44 cells 
expressing EGFP-dLacI (clone 7) cells.  Selection was performed using 7.5µg/ml 
puromycin (Sigma) to generate the “C42” cell clone pSP14_5’UTR_MS2_HSP70_42.  
C42 cells were transfected with the EGFP-SON-BAC and selected using 200 µg/ml 
Zeocin to generate cell clone C42-165J2-C16_C4_1.  C42-165J2-C16_C4_1 cells were 
transfected with either CENPA-mCherry or Ub-MS2bp-mCherry and selected using 400 
µg/ml G418 selection to generate C42-165J2-CENPA-mCh-C36 or C42-165J2-
UbMS2mCh-B, respectively. 
CHO-K1 cells were grown in F12 media (Invitrogen) supplemented with 10% 
Fetal Bovine Serum (Sigma), at 37°C with 5% CO2.  The HSPA1B-3’UTR-MS2 BAC 
was transfected into CHO-K1 cells, and selected using 400 µg/ml G418, generating cell 
clone CHO-K1-HSPBAC-3’MS2-C2.  Cell clone CHO-K1-HSPBAC-3’MS2-C2 was 
stably transfected with mCherry-dLacI and selected using 200 µg/ml Hygromycin, 
generating cell clone CHO-K1-HSPBAC-3’MS2–mCh-dLacI-C15.  The GFP-SON-Zeo 
BAC was stably transfected into cell clone CHO-K1-HSPBAC-3’MS2–mCh-dLacI-C15 
using 200 µg/ml Zeocin to isolate cell clone CHO-K1-HSPBAC-3’MS2-mCh-dLacI-
165J2-C24. 
 
RNA FISH, Drug Treatment, Transient Transfections: 
RNA FISH was performed as described previously[1]. 
Cells were treated with latrunculin A (Calbiochem) for 5 min to disrupt actin 
polymerization or with jasplakinolide (Calbiochem) for 30 min to inhibit actin 
 
 
 93 
depolymerization, both at final concentrations of 1µM.  Drug inhibition was followed by 
a 30 min heat shock.   
Transient transfection with plasmids expressing mRFP-actin-NLS (containing 
wild type beta-actin) or with mRFP-G13R actin-NLS (containing non-polymerizable 
beta-actin mutant G13R)[6] was performed using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s directions; speckle association was analyzed after 48 hrs.   
 
Microscopy and data analysis: 
For microscopy of fixed cells, an Applied Precision personal DeltaVision 
microscope system (GE Healthcare) with a 60X (1.4 NA) objective lens and a CoolSNAP 
HQ2 CCD camera was used.  For microscopy of live cells, an Applied Precision V3 OMX 
microscope system (GE Healthcare), with a 100X objective (NA 1.40) and two Cascade 
II EMCCD cameras was used.  Live cells were maintained at 5% CO2 at the desired 
temperature in a heated, humidified chamber on the microscope (GE Healthcare) that was 
used in conjunction with an objective lens heater.  Heat shock was implemented by 
raising the temperature of both the chamber and the lens heater.  Live-cell imaging data 
was aligned using StackReg (7) in ImageJ (National Institutes of Health) to correct for 
changes in nuclear translation and rotation, as well as uniform shape changes that can be 
described by a change in x-y magnification.  2D projections of 3D data were calculated 
for each time point.  StackReg uses a cross-correlation method to find the affine 
transformation that optimizes the fit between 2D projections at adjacent time points.  
Alignment was applied consecutively from the beginning to end time points, using RGB 
image for alignment when both GFP and mCherry channels were used. 
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Deconvolution used an enhanced ratio, iterative constrained algorithm within the 
Applied Precision SoftWorx software (8). All quantitative measurements were performed 
using ImageJ.  Measurements of RNA signals were made from projected (method sum 
slices) deconvolved image stacks.  To correct for mCherry photobleaching during live-
cell imaging, the integrated mCherry intensity for the entire projected nucleus as a 
function of time was fit to an exponential model using least-squares regression (JMP 
software, SAS Institute, Inc.)  This exponential model was then used to calculate 
multiplicative normalization scale values to correct for the loss of mCherry signal at each 
time point. The sum of RNA intensity values within a region of interest in the projected 
image was calculated; the integrated signal from an adjacent region within the nucleus of 
equal area was measured and this was subtracted from the integrated RNA signal to 
produce a background-corrected RNA integrated intensity value.  
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APPENDIX B 
Supplementary Data for Chapter 3 
Figures: 
 
Figure B.1. Experimental approach for identifying peripheral targeting cis regions.   
 
 
BAC recombineering is used to delete specific regions from a BAC containing the LacO 
repeat.  These BACs are then randomly integrated into NIH 3T3 cells and peripheral 
targeting is visualized by EGFP-lac repressor binding in multiple, independent subclones.  
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Figure B.2. The beta-globin BAC transgenes in individual NIH 3T3 mouse 
fibroblasts recapitulate the radial nuclear localization pattern of the endogenous 
human beta-globin locus in human fibroblasts.    
 
 
 
Histograms of distances between the nuclear periphery and endogenous beta-globin loci 
in BJ-hTERT cells (A) or the BAC transgenes in clone HBB C3 (B) n>50, data shown is 
pooled from at least 2 independent experiments. 
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Figure B.3. Genomic coordinates of human beta-globin BAC (CTD-2643I7) and 
deletions.   
 
 
(A) Schematic representation of human beta-globin BAC, with genomic coordinates 
labeled according to the hg19 assembly (gene coordinates relative to HBB transcription 
start site) (B-C) genomic coordinates for all deletions, shown by red lines. 
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Figure B.4. Knockdown experiments do not support a cKrox dependent, redundant 
mechanism for peripheral tethering of HBB flanking sequences in Tig3ET cells. 
 
 
Statistics from DNA FISH showing no change in peripheral localization after cKrox 
siRNA knockdown (cKrox KD), combined cKrox siRNA /Suv39H1/H2 shRNA 
knockdown (me3/cKrox KD), or BIX G9a inhibition (me2 KD) for HBB BAC probe (A) 
or RP11-715G8 BAC probe containing predicted GA motif.  (B-D) H3K9me3 
immunostaining after shRNA with control, scrambled sequence (C) or combined 
Suv39H1 and Suv39H2 shRNA (me3 KD) (D).  (E-F) Western blots showing siRNA 
mediated knockdown of cKrox (E) and H3K9me2 reduction after BIX01294 (BIX) 
inhibition of G9a.  ~50% reduction in total H3K9me2 is consistent with expectation for 
fraction of H3K9me2 modification mediated by G9a (see text).   (A,B) n > 50, data 
shown is pooled from at least 2 independent experiments.  Scale bars= 2µm. 
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Figure B.5.  Both H3K9me3 and H3K9me2 are enriched in a peripheral chromatin 
rim in different human and mouse fibroblast cell lines.   
 
 
Double immunostaining for H3K9me2 (green) and H3K9me3 (red) modifications 
together with DAPI DNA staining (blue) in human and mouse fibroblast cell lines: (A) 
TIG3 human fibroblasts; (B) WI38 human fibroblasts; (C) mouse NIH 3T3 fibroblasts.  
Relative ratio of peripheral H3K9me3 versus H3K9me2 staining appears to vary with cell 
line, with H3K9me3 more pronounced for instance in WI-38 versus TIG3 cells.  
Immunostaining also reveals examples of alternating foci of H3K9me3 and H3K9me2 
along the periphery (most obvious in merged color TIG3 image (A)), suggesting 
independent targeting of H3K9me3 versus H3K9me2 enriched chromatin domains to 
periphery.  Scale bars= 2µm. 
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Tables: 
Table B.1.  Primers used for BAC recombineering experiments. 
 
Check Primers 
 
D1-Check-F 
D1-Check-R 
D2-Check-F 
D2-Check-R 
D3-Check-F 
D3-Check-R 
D4-Check-F 
D4-Check-R 
D5-Check-F 
D5-Check-R 
D7-Check-F 
D7-Check-R 
D8-Check-F 
D8-Check-R 
D9-Check-F 
D9-Check-R 
D10-Check-F 
D10-Check-R 
HBBD8D11-Check-F 
HBBD8D11- Check-R 
HBBD8D12- Check-F 
HBBD8D12- Check-R 
HBBD8D13- Check-F 
HBBD8D13- Check-R 
HBBD8D13D22- Check-F 
HBBD8D13D22- Check-R 
HBBD8D14- Check-F 
HBBD8D14- Check-R 
HBBD8D17- Check-F 
HBBD8D17- Check-R 
 
 
 
 
 
5’-tttgcttccacatcaatcca-3’ 
5’-gcctgtttgggtttgcttta-3’ 
5’-actagggggctggtgaagtt-3’ 
5’- tgatgcctcctttgcttctt-3’ 
Same as D1-Check-F 
Same as D2-Check-R 
5’-aaacgagtggtcctgtttgg-3’ 
5’-tgcaaccttgctagcatctg-3’ 
5’-tcttgccccattaccaatgt-3’ 
5’-agctcaggagttggagacca-3’ 
5’-gttttcccagtcacgacgtt-3’  
5’-gttttcttggttgccacgat-3’  
Same as D7 check F 
5’-gcagcacacgttctgatttc-3’ 
Same as D7 check F 
5’-tttgacatgaggcacaatgc-3’ 
5’-caggaaagggaactccatga-3’  
D10 CHECK R: same as D7 check R 
Same as D7-Check-F 
5’-aaaggaactgcagcaggaaa-3’ 
Same as D7-Check-F 
5’-agggatgaggcaaaggtttt-3’  
Same as D7-Check-F 
5’-gtgatgagcttcctccaagc-3’ 
5’-agatgtgtataagagacag-3’ 
5’-tctgccattctcttcctcct-3’ 
Same as D10-Check-F 
Same as D4-Check-R 
5’-tcacccagaggtgtgtcaaa-3’ 
5’-gttttcttggttgccacgat-3’ 
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Table B.2.  Primers used for RT-qPCR and ChIP. 
GAPDH (1) GF4-N ATCCTGTAGGCCAGGTGATG 
 
GR4-N AGGCTCAAGGGCTTTTAAGG 
   IAP (1) IAP-F1 CGTGAGAACGCGTCGAATAA  
 
IAP-R1 TTCTGGTTCTGGAATGAGGG 
   
   KN-1 (2) KNF CGGATGGAAGCCGGTCTTGTC 
 
KNR AGAAGGCGATAGAAGGCGATG 
   KN-2 KNFP2 GGATGATCTGGACGAAGAGC 
 
KNRP2 GGCCATTTTCCACCATGATA 
   mouse hbb (3) QF12M GCACCTGACTGATGCTGAGA 
 
QR12M CTGGGTCCAAGGGTAGACAA 
   beta-actin (3) Actb-F TTGCTGACAGGATGCAGAAG 
 
Actb-R ATCCACATCTGCTGGAAGGT 
   hbb-1 (4) QF1  AGGAGAAGTCTGCCGTTACTG 
 
QR1 CCGAGCACTTTCTTGCCATGA 
   hbb-2 (5) QF2  ATGGTGCATTTTACTGCTGAGG 
 
QR2 GGGAGACGACAGGTTTCCAAA 
   OR-1 (6) QF6  TCTACCTCATCAAGCATGACCA 
 
QR6 TGCCCATTACAGTAGGCATCG 
   OR-2 (7) QF7  CCTATGGGTGAATCACAGGGA 
 
QR7 GCATATCTCAAAGGATTGCGGAT 
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Table B.3.  SMARTpool siRNA target sequences. 
cKrox 
 
GCCACAAGGCUUUCGCCAA 
  
AAGAAGAGGAGCUGGUAUA 
  
GGUCUGCGGUGUUCGAUUC 
  
GGACGCAGGGCCUUGAAUA 
   
   SUV39H1 
 
GGUGAAAUGGCGUGGAUAU 
  
CUAAGAAGCGGGUCCGUAU 
  
CCAACUACCUGGUGCAGAA 
  
GAACCUCUAUGACUUUGAA 
   
   SUV39H2 
 
ACAGAUUGCUUCUUUCAAA 
  
UAAAGACCCUUGUGAAGAU 
  
GAAGCUACCUUUGGUUGUU 
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APPENDIX C 
 
BAC Manipulations for Making BAC Transgene Arrays1 
 
Summary: 
 
 Chromosome tagging using lac or tet operator repeats for in vivo visualization of 
chromosome dynamics has now become a standard methodology used in a range of 
organisms.  One variation of this approach has been to build transgene arrays creating 
artificial chromosome blocks to study various aspects of chromatin structure, 
transcription, replication, or DNA repair.  Previously, plasmid transgenes with or without 
subsequent gene amplification have been used to build these arrays.  However, plasmid 
arrays typically show heterochromatic properties while gene amplification typically 
results in chromosome instability of the amplified regions.  To avoid these problems, we 
are now building transgene arrays from large genomic DNA inserts cloned in bacterial 
artificial chromosomes (BAC).  These BAC transgenes show transcriptional levels within 
several fold of endogenous genes while also exhibiting targeting to specific nuclear 
compartments similar to the targeting of the endogenous genes.  Here we describe Tn5 
transposition and BAC recombineering methods used to retrofit BACs for their use in 
building BAC transgene arrays.  This includes insertion of operator repeats and selectable 
markers into these BACs as well as targeted insertion or deletion of BAC sequences. 
 
 
                                                
1 This chapter appeared in its entirety in Methods in Molecular Biology. Nimish Khanna, 
Qian Bian, Matt Plutz, Andrew S. Belmont (2013) BAC Manipulations for Making BAC 
Transgene Arrays. Methods Mol Biol. 2013;1042:197-210. doi: 10.1007/978-1-62703-
526-2_14. PMID: 23980009. 
 
Author	  Contributions:	  N.	  K.,	  Q.B.,	  and	  M.P.	  carried	  out	  experiments.	  A.S.B.	  supervised	  the	  study	  and	  together	  with	  N.K.	  and	  Q.B.	  wrote	  the	  paper.	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Introduction: 
 
Belmont laboratory has used three generations of approaches to build large 
transgene arrays or engineer large blocks of chromosomes (1). At first we used plasmid 
transgenes, containing a 256mer lac operator repeat plus a cDNA DHFR (dihydrofolate 
reductase) minigene, followed by gene amplification using methotrexate selection. This 
first generation approach yielded gene amplified regions of varying sizes and chromatin 
compaction levels.  However, whereas the amplified regions were stable in their 
characteristic compaction levels, they were unstable in size and chromosome location.  In 
the second generation approach, we used plasmid constructs containing anywhere from 
32 to 256 copies of the lac operator, a selectable marker, and also endogenous promoters 
and/or cis-regulatory elements of specific genes driving reporter gene expression or intact 
transgenes.  Multi-copy plasmid transgene arrays were stable in both size and 
chromosome location; however, they typically showed condensed chromatin and 
variegated expression of transgenes contained in these arrays. 
 In our third generation approach, we used BACs rather than plasmids to generate 
transgene arrays.  By using BACs containing large ~100-250 kb insertions of mammalian 
DNA we generated more normal chromatin compaction (2), with BAC transgenes 
forming large-scale chromatin fibers indistinguishable to the surrounding euchromatin 
regions as visualized by electron microscopy (3).  These BAC transgene arrays show 
stable size and chromosome location, with transgene expression levels within several fold 
of endogenous genes (2,4).  Moreover, both HSP70 and beta-globin BAC transgenes 
recapitulated the observed targeting of their endogenous gene counterparts to nuclear 
speckles and the nuclear periphery, respectively.  Together our results suggest that BAC 
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transgene arrays recapitulate the behavior of endogenous chromatin much better than the 
previously used gene amplification and plasmid based systems.  Current work in our 
laboratory is focused on using BACs to create transgene arrays in order to study large-
scale chromatin structure and chromatin dynamics and their relationship to transcriptional 
regulation.  Technically, this requires inserting operator or MS2 repeats into the BAC to 
tag DNA or RNA sequences, inserting reporter genes into the BAC to assay 
transcriptional competence, and deletion analysis to dissect cis regulatory elements 
regulating the large-scale chromatin structure of BAC transgenes. The large size of these 
BACs, however, precludes traditional cloning methods.  Instead, we have been using Tn5 
transposition to retrofit BACs with operator arrays and/or selectable markers and BAC 
recombineering to add or delete specific DNA sequences at defined locations.   
Tn5 transposition is a relatively simple and fast method for introducing DNA 
sequences into a BAC.  In vitro incubation of a DNA transposon, constructed to contain 
the DNA element to be inserted, with the BAC DNA and a commercially available Tn5 
transposase enzyme is followed by a E. Coli transformation to select colonies containing 
BACs with transposon insertions.  Although insertion is random, a large number of 
bacterial clones, each containing a BAC with a different insertion site, are obtained in a 
single reaction.  DNA sequencing can then be used to screen for a suitable BAC insertion 
site. 
 Methods for homologous recombination allow for insertion or deletion of DNA 
sequences at specific sites within the BAC.  However, homologous recombination 
methods involving transient expression of RecA lead to recombination among direct 
repeats such as lac operator or MS2 arrays.  We therefore instead have been using BAC 
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recombineering with the λ- red system (5).  With this system recombination is limited 
typically to just the several hundred bps at the ends of linear DNA fragments, sparing 
internal fragment sequences and, in particular, direct repeats inserted into the BACs.  
The λ- red system is a powerful bacterial recombination system as it requires only short 
homology arms to perform recombination at high fidelity.  The three λ- red phage genes 
(Exo, Bet and Gam) required for recombineering are integrated into the E.coli genome 
and their expression is under tight control of the temperature sensitive λ-cI857 repressor.  
At 32˚C expression of the λ-red recombination machinery is suppressed by the λ-cI857 
repressor. When the temperature is shifted to 42˚C for 15 minutes, the repressor is 
inactivated and the recombination machinery is expressed at a level allowing high 
frequency of recombination. 
For many applications, the removal of the selectable marker after the first round 
of recombineering is necessary.  Both positive and negative selection are possible using 
the E. Coli galK as a selectable marker.  The galK gene encodes galactokinase, which is 
essential for utilizing galactose, allowing positive selection using galactose as the carbon 
source.  Negative selection is provided by growth in the presence of the galactose isoform 
2-deoxy-galactose (DOG), as galK catalyzed phosphorylation of DOG generates the toxic 
2-deoxy-galactose-1-phosphate.  To employ galK gene as the selectable marker, the 
endogenous galK gene was removed from the bacterial genome to generate a specialized 
strain. The BAC to be modified needs to be introduced into this strain. A linear DNA 
fragment containing galK gene can then be integrated into the BAC by homologous 
recombination. The recombinants are selected on minimal medium in which galactose is 
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the only carbon source.  GalK can then be removed by another round of recombination 
using negative selection.  
We initially adopted the galK recombineering system (5) for insertion of DNA 
sequences, which uses a two step procedure in which the galK selectable marker is first 
inserted and then replaced with the desired DNA fragment to be inserted.  However, the 
primary application of this system apparently was for introduction of point mutations or 
very small DNA insertions. We observed a pronounced size dependence of 
recombination efficiency for larger fragments.  When trying to insert a 4 kb DNA 
fragment, all colonies selected based on loss of galK expression contained large BAC 
deletions spanning the region with the galK marker or mutations in the galK gene.  We 
reasoned that the large size of our DNA fragment led to a frequency of homologous 
recombination in the small percentage of cells transformed with the DNA fragment 
significantly lower than the spontaneous background frequency of BAC mutation and 
deletion occurring in the vast excess of plated E. Coli cells. 
To solve this problem, we revised the scheme of the two-step recombination to 
achieve the "seamless" insertion of large DNA sequences into BACs (Fig. C.1). A 
targeting fragment containing three homology arms A, B and C, each with a typical size 
of 45-50bp, is constructed. The galK selectable marker is then inserted between 
homology boxes B and C and the DNA sequence, X, to be inserted is inserted between 
homology boxes A and B.  This fragment is then introduced to bacteria carrying the 
target BAC leading to recombination between homology boxes A and C and insertion of 
both galK and X.  These recombinants are efficiently selected for using galK positive 
selection. To remove galK, a DNA fragment containing homology boxes B and C is 
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generated by PCR using the BAC DNA as template and used for galK deletion by 
homologous recombination.  Because of the small fragment size, recombination is 
sufficiently efficient to compete with the background rate of spontaneous loss of galK by 
mutation or large, internal BAC deletions. As a result, 20%-50% of total colonies after 
DOG selection are correct recombinants, which can be screened relatively easily. 
Here we describe three protocols used in our laboratory to insert DNA sequences into 
BACs or to make deletions at specific sites.  Protocol 1 is for random insertion of DNA 
sequences by Tn5 transposition.  Protocol 2 is for addition of DNA sequences using BAC 
recombineering.  In this second protocol we have modified the original λ- red 
recombineering approach to facilitate the insertion of large DNA fragments into BACs.  
Protocol 3 is for making deletions in BACs using BAC recombineering.  
 
Materials: 
Transposition reaction: 
1) EZ-Tn5™ kit (Epicentre Technologies) 
2) pMOD-2 vector (Epicentre Technologies) 
3) BAC maxi prep kit (we use Qiagen’s large construction kit). 
4) Restriction enzymes 
5) Electrocompetent cells (we use Epicentre’s TransforMax EC100 
Electrocompetent E. coli) 
6) LB and SOC media 
7) Electroporator (we use Biorad Gene Pulser II) 
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8) Cuvette for electroporation (we use the 0.2 cm electrode gap cuvette from 
Biorad). 
 
BAC Recombineering:  
1) E. coli SW102 strain 
2) pgalK construct 
3) 1X M9 Medium (1 L): 6 g Na2HPO4, 3 g KH2PO4, 1 g NH4Cl, 0.5 g NaCl. 
Autoclave the medium. 
4) 5X M63 medium (1 L): 10 g (NH4)2SO4, 68 g KH2PO4, 2.5 mg FeSO4·7H2O. 
Adjust to pH 7 with KOH and autoclave. 
5) M63-Gal minimal plates: M63, 45 mg/ml L-Leucine, 1 mg/ml D-Biotin, 0.2% D-
(+)-Galactose, 15 g/l Agar, 12.5 mg/ml Chloramphenicol  
6) M63-DOG minimal plates: M63, 45 mg/ml L-Leucine, 1 mg/ml D-Biotin, 0.2% 
Glycerol, 0.2% 2-Deoxy-D-galactose, 15 g/l Agar, 12.5 mg/ml Chloramphenicol.  
7) MacConkey plate: 1% D-galactose, 15 g/l MacConkey agar, 12.5 mg/ml 
Chloramphenicol. 
8) Low salt LB medium (1 L): 10 g Bacto-tryptone, 5 g yeast extract, 5 g NaCl. 
a. Adjust to pH 7 with NaOH, and autoclave. 
9) Autoclaved Conical flasks, centrifuge tubes 
10) Autoclaved ddH2O 
11) Shaking water baths (320C and 420C) 
12) 320C incubator 
13) Antibiotics (Chloramphenicol, Kanamycin, etc.) 
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14) SOC medium 
15) Electroporator (we use Biorad Gene Pulser II) 
16) Cuvette for electroporation (we use the 0.2 cm electrode gap cuvette from 
Biorad). 
 
Methods: 
Protocol 1. Transposon insertion reaction (adapted from Epicentre): 
1) Prepare the custom transposon by cloning the DNA of interest into the Multiple 
Cloning Site (MCS) of the pMOD-2 vector. 
2) Isolate the functional EZ -TN5 transposon by either restriction enzyme digestion 
with PshA1 or PvuII (see Note 1) or PCR amplification.  
3) Isolate the target BAC DNA by maxi preparation (see Note 2). 
4) Prepare the transposon insertion reaction mixture by adding in the following 
order:  
0.5 µl EZ-Tn5 10X Reaction Buffer  
0.1 µg target BAC DNA  
x µl molar equivalent [Kan/Neo-8.32] transposon 
x µl sterile water to bring reaction volume to 4.5 µl  
0.5 µl EZ-Tn5 Transposase  
5 µl Total reaction volume  
            Calculation of µmole target DNA:  
µmole target DNA = µg target DNA / [(# base pairs in target DNA) x 660]  
5) Incubate the reaction mixture for 2 hours at 37°C. 
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6) Stop the reaction by adding 0.5 µl of 10X Stop Solution. Mix and heat for 10        
minutes at 70°C.  
7) Proceed to Transformation and Recovery (steps 8-9) or store the reaction mixture 
at –20°C. 
8) Transform 1µl of the transposon insertion reaction mixture into 50 µl of a recA- 
and endA- electrocompetent bacterial strain (see Note 3).  
For electroporation we use the 0.2 cm electroporation cuvette and the Bio-Rad 
electroporator with the following settings: Resistance=200 Ω, Capacitance= 25 µF 
and Voltage= 2.5kV. 
9) Recover the electroporated cells by adding 950 µl SOC medium to the 
electroporation cuvette. Tap gently to mix. Transfer to a tube and incubate on a 
37°C shaker for 1 hour to facilitate cell growth. 
10) Plate 1/10 and 9/10 volume of cells onto selective medium (see Note 4) as 
dictated by the transposon insert and grow plates overnight at 37°C.    
11) Inoculate several individual colonies into 5 ml LB containing antibiotics. Use 4 
ml of the overnight culture for mini-prep. Check the restriction digestion patterns 
of the DNA to make sure there are no unwanted rearrangements within the BAC. 
Freeze down the clones with correct digestion patterns.   
12) Sequence the BACs with insertions from both ends of the transposon to identify 
the transposon insertion site and to verify that no BAC sequence was lost during 
insertion. 
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Protocol 2: BAC recombineering for addition of DNA sequences: 
Transform BAC into E.coli SW102 strain: 
1) Purify the BAC DNA by mini-prep protocol. The integrity of the BAC DNA 
should be checked by restriction digestion pattern generated by appropriate 
restriction enzymes. 
2) The day before transformation, inoculate a 2 ml LB culture with SW102 cells. 
Grow the culture overnight in a 32˚C shaking waterbath. 
3) Inoculate a 25 ml low salt LB culture in a flask with 0.5 ml of the overnight 
culture and grow the culture at 32˚C to an OD600 value of 0.55-0.6 (which takes 
about 3-4 hours). 
4) Prepare an ice-water bath before the culture is ready. Cool down ddH2O and the 
centrifuge tubes on ice.  
5) When the culture is ready, incubate it on ice for 5-10 minutes. Then aliquot 12.5 
ml culture to each centrifuge tube.  
6) Centrifuge the culture at 3,000 g for 5min at 4˚C. Pour off the supernatant. Put the 
tubes back into the ice-water bath. Then add 1ml of ice-cold ddH2O to each tube. 
Swirl the tube in the ice-water slurry until the pellet is completely resuspended. 
Add 9 ml more ice-cold ddH2O to the tube to bring the total volume to 10 ml, then 
swirl briefly.  
7) Repeat step 6. The pellet will become much looser after this centrifugation. The 
supernatant should be removed with a 10 ml serological pipette with caution. 
Remove as much supernatant as possible without disturbing the pellet. Add 9 ml 
of ice-cold ddH2O to the tube and swirl briefly. 
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8) Centrifuge again. After this centrifugation, remove as much supernatant as 
possible; this usually leaves 0.5-1 ml of supernatant in the tube. Resuspend the 
pellet with a pipetman and transfer the cell suspension from each tube to the 
autolcaved 1.5ml microcentrifuge tube on ice. 
9) Centrifuge the suspension using a benchtop centrifuge machine in a 4˚C room at 
1,000 g for 5 min. Remove supernatant to reduce the volume to about 100 µl per 
tube. These electrocompetent cells are ready for the transformation. 
10) Add 1-2µl (50-100ng) of the mini-prepped BAC DNA to 50 µl of the SW102 
competent cells. Mix DNA with competent cells by gently tapping the tube.  
11) Perform electroporation following the procedure used in Protocol1. 
12) Recover the cells by adding 950 ul of SOC medium. Shake in a 32˚C waterbath 
for 1hr. 
13) Plate 100 µl (1/10 of the total cells) on a LB plate containing 12.5 µg/ml 
chloramphenicol. Incubate the plate in a 32˚C incubator. The colonies should be 
ready to pick after ~24 hours incubation.  We typically obtain 104-105 colonies per 
µg DNA starting from miniprep BAC DNA (which is not as pure as BAC DNA 
from a maxi prep using endonuclease treatment). 
14) Inoculate several isolated colonies into 5 ml LB cultures containing 
chloramphenicol (12.5 mg/ml). Use 4 ml of the overnight culture for mini-prep 
DNA preparation. Check the restriction digestion patterns of the DNA to make 
sure there are no unwanted rearrangements with in the BAC. Freeze down clones 
with correct digestion patterns.  
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Generation of a DNA fragment containing the homology regions, the galK selection 
cassette, and the sequence to be inserted: 
To simplify cloning, an oligonucleotide containing homology regions A, B and C, and 
appropriate restriction sites can be synthesized. Then galK and the DNA sequence of interest 
(X) can be inserted at these restriction sites (Fig. C.1A). 
1) Determine the desired site for insertion of the DNA sequence of interest in the 
BAC. The 50 bp regions flanking this targeting site can be picked as homology 
regions A and B. The 50 bp region downstream of B can be picked as homology 
region C. Check the restriction sites within the regions A, B and C and make sure 
they do not contain sites that will be used later for cloning. Then add the 
sequences of the restriction sites between the homology regions (we typically use 
EcoRI restriction site to insert galK cassette between B and C). In addition, flank 
both ends of the oligonucleotide sequence with a rare restriction site that can be 
used to excise this DNA fragment. 
2) Transform the commercially synthesized oligonucleotide, cloned within a vector, 
to an appropriate E.coli strain (e.g. DH5a, Stbl2 etc.). Purify the plasmid DNA. 
Insert the galK selection cassette, which can be digested from the pgalK plasmid 
(we typically use EcoRI restriction), into the site between homology regions B 
and C. Screen for correct clones. 
3) Insert the sequence X into the site(s) between homology regions A and B. Screen 
for correct clones. 
4) Purify the plasmid DNA. Digest the plasmid with restriction enzymes that cut the 
ends of the oligonucleotide to release the five-element fragment. 
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5) Gel purify the five-element fragment. The concentration of the purified fragment 
should be at least 20 ng/µl. 
 
Insertion of the sequence of interest into the BAC followed by Gal selection: 
1) The day before recombination, inoculate a 2 ml LB culture containing antibiotics 
with the SW102 bacteria clone carrying the BAC to be modified. Grow the 
culture overnight in a 32˚C shaking waterbath. 
2) Inoculate a 25 ml low salt LB culture with 0.5 ml of the overnight culture and 
shake at 32˚C. Grow the culture to an OD600 of ~0.55-0.6.  
3) After the culture reaches the optimal density, split the culture in half. Transfer 
12.5 ml of the culture into a 30 ml centrifuge tube and leave it on ice. This will be 
used as the uninduced control for recombination. Heat-shock the other half of the 
culture at 42˚C for 15min in a shaking waterbath. After heat-shock, cool down the 
culture on ice for 5-10 min, and then transfer it to a 30 ml centrifuge tube. 
4) Follow steps 6-9 in Protocol 3.  
5) Transform 5 µl of the DNA fragment prepared in Protocol 3 to 50 µl of both 
induced and uninduced SW102 competent cells. Recover the cells with 950 µl of 
SOC medium and shake in 32˚C waterbath for 1hr. The recombination reaction 
will occur in the bacteria during this period. 
6) After recovery, transfer the 1 ml cultures to autoclaved eppendorf tubes. Spin the 
cells down with a benchtop centrifuge at top speed for 1min.  
7) Carefully remove the supernatant. Resuspend the pellet thoroughly with 1 ml of 
M9 minimal medium. Then centrifuge again. 
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8) Repeat step 6.   
9) Remove the supernatant and resuspend the pellet with 1ml M9 minimal medium. 
Plate 1/10 and 9/10 of the induced and uninduced samples on M63-Gal minimal 
plates. 
10) Incubate the plates in a 32˚C incubator. The plates should be placed into humid 
containers as they may dry out. The colonies should become obvious by day 3 of 
selection and reach a desirable size at day 3 or 4 (See Notes 5 and 6).  We 
typically get tens to hundreds of colonies per plate for the 9/10 dilution. 
 
Screening for clones carrying correctly recombined BACs: 
After drug selection, colony PCR can be used to confirm whether the DNA 
sequence of interest is inserted into the correct site within the BAC. The PCR primers 
that bind to the regions flanking homology boxes can be used to amplify the regions 
between them in the engineered BAC. The size of the product will indicate whether there 
is an insertion in the desired location.  Alternatively, when the insertion is too large for 
efficient PCR, we use two primer pairs to check both ends of the insertion.  Each primer 
pair consists of one primer binding to a region outside of the homology box within the 
BAC and one primer binding to a region flanking the insertion site.   
After PCR verification of homologous recombination, restriction digests should be 
performed to rule out BAC DNA rearrangements or deletions and, when operator repeats 
are present, shortening of these repeats. 
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Generation of DNA fragment for removing galK: 
A second round of recombination followed by negative selection can be used to 
remove galK.  Since galK is inserted between homology regions B and C, a DNA 
fragment consisting of homology regions B and C can be generated by PCR and used for 
recombination (Fig. C.1B). 
1) Design a pair of primers that match the ends of homology region B and C and 
perform standard PCR using the unmodified BAC DNA as the template. 
2) Purify the PCR product using a Qiagen PCR purification kit. The concentration of 
purified fragment should be at least 20 ng/µl. 
 
Removal of galK using negative selection with DOG: 
1) Streak the glycerol stock galK-positive clone onto a MacConkey plate to obtain 
single colonies (see Note 7). Incubate the plate at 32˚C. Bright red colonies 
should become obvious after 24 hours. 
2) Pick one bright red colony from the MacConkey plate and inoculate a 2ml culture 
containing antibiotics. Shake overnight at 32˚C. 
3) Inoculate a 25 ml culture with 0.5 ml of overnight culture. Grow the culture to an 
OD600 of 0.55-0.6. 
4) Heat shock the culture at 42˚C for 15 min. 
5) Follow steps 6-9 in Protocol 3. 
6) Electroporate 50 µl of the electrocompetent cells with 5 µl of the DNA fragment. 
As a control, electroporate another 50 µl of cells with 5 µl of water (see Note 8). 
Recover the cells in 5 ml LB for 4.5 hours at 32˚C. 
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7) As in Protocol 3, pellet 0.5 ml of the recovered culture and wash twice with 1xM9 
salts. Then make two serial dilutions with 1xM9 salts. Plate 100 µl of the 
resuspended pellet (1/100 of the total cells), 100 µl of a 1:10 dilution (1/1000 of 
the total cells) and 100 µl of a 1:100 dilutions (1/10000 of the total cells) on DOG 
plates. Incubate at 32˚C for 3 days. We typically see tens to hundreds of colonies 
at the 1:1000 dilution.  The number of colonies on the recombination plates may 
not be significantly different to the control plates (could vary from 1:1 to 100:1). 
Screen 20-30 colonies from the recombination plate.  
 
Screening for clones carrying correctly recombined BACs: 
Following galK removal, recombinants should again be screened using colony 
PCR. Following PCR screening, restriction digest fingerprinting should be performed to 
confirm the correct arrangement of the BAC sequences. By choosing appropriate 
restriction enzymes the loss of the ~1.5 kb galK fragment should be obvious. 
 
Protocol 3: Deletion of specific BAC sequences using galK as the dual selectable 
marker: 
BAC recombineering provides a convenient system for deleting specific 
sequences from the BAC. Using this method we have deleted regions ranging from 3-116 
kb. The use of galK as the selectable marker allows the subsequent removal of galK by 
negative selection allowing multiple, sequential deletions to be made. 
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Generation of a DNA fragment containing homology regions and galK using PCR: 
The recombination fragment for making deletions can be conveniently generated 
using PCR. The sequences flanking the region to be deleted are chosen as the homology 
boxes (Fig. C.2A). The PCR primers should consist of two parts, the 17bp sequence 
homology to the template pgalK and the 43 bp homology box, similar to the primers 
described in Protocol 3. 
The 17bp sequences we typically use to PCR amplify galK are: 
Forward primer: 5’-cgacggccagtgaattg-3’, Reverse primer: 5’-tgcttccggctcgtatg-3’  
It is critical to completely remove the intact pgalK template from the PCR product by 
doing both DpnI digestion and gel extraction.  
 
Deletion of sequences followed by Gal selection: 
The experimental procedure is exactly the same as Protocol 3. The uninduced 
control should give nearly zero colonies while the one tenth dilution of the induced 
sample should give dozens to hundreds of colonies after the selection.  
 
Screening for clones carrying correctly recombined BACs: 
Colony PCR can be used to screen the recombinants. The PCR primers flanking 
the deleted region should be used, with the intact BAC before the deletion serving as a 
negative control. Following this PCR screening, restriction digests should be performed 
to confirm the deletion and the integrity of the BAC. Freeze down the colonies with 
correct digestion patterns. 
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Generation of the DNA fragment for removing galK: 
DNA fragments for removal of galK are generated by PCR using 60bp primers 
partially complementary to each other. Each of the 60bp primers consists of a 52bp 
homology region flanking the galK marker and a 8bp sequence complementary to the last 
8 bp of the other homology region. This will give rise to a 16bp complementary region 
between the two primers. For PCR, no extra template is needed (Fig. C.2B).  
 
Removal of galK followed by negative selection with DOG: 
The experimental procedures are exactly the same as Protocol 3. 
 
Notes: 
Transposon insertion reaction: 
 No colonies on the selective plate after transposon insertion reaction:  
1) Disruption of the mosaic ends (ME) of the isolated custom transposon:  
a. PshAI restriction enzyme, which is one of the enzymes used for isolating 
the transposon, might show star activity if incubated for too long at 370C, 
disrupting the efficiency of transposition. To avoid this possibility, we 
typically digest with PshAI restriction enzyme at 250C for the least 
possible time. 
b. To test the custom transposon preparation, perform the control transposon 
insertion reaction of the isolated transposon with the control target 
provided with the kit.  
 
 
 122 
c. Sequence the transposon construct to verify the sequence of the ME and 
the flanking regions. 
2) Sheared or contaminated target BAC DNA: to rule out the possibility of sheared 
BAC or the presence of inhibitors in the BAC DNA, perform the control 
transposon insertion reaction of the maxi prep BAC DNA with the control 
transposon provided with the kit.  
3) Low competence of the electrocompetent cells used for transformation: if 
competent cells have a transformation efficiency <108 cfu/µg DNA, one may not 
obtain sufficient colonies after transposon insertion on the selective plate.  
4) High concentration of the selective drug in plates:  survival of the successfully 
transposed colonies might require lower than the conventionally used antibiotic 
concentration. For example, for kanamycin selection we get colonies only after 
reducing the concentration to 20mg/ml. 
 
BAC Recombineering: 
galK selection: 
1) Colonies in the uninduced control:  
a. Contamination from the uncut plasmid: uncut plasmid harboring galK 
transforms very efficiently and comprises most of the background. Make 
sure that there is no contamination from the uncut plasmid. 
b. Incorrect composition of the selective plates: There should not be any 
other source of carbon in M63-Gal minimal plates apart from galactose. 
2) No colonies in the induced sample:  
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a. Low recombination efficiency:  for insertion of long or repetitive DNA 
sequences, increasing the length of the homology arms might help in 
increasing the recombination frequency.  This is also true when there are 
internal sequences in the DNA fragment to be inserted with homology to 
other regions in the BAC outside the targeted region. 
b. Absence of prophage needed for recombineering: The SW102 bacteria 
need to be grown at 320C. They should never be grown at 370C. SW102 
bacteria die at 370C; only those SW102 bacteria that are defective for 
recombineering survive at this temperature. 
galK counterselection: 
1) Carry-over of SW102 cells containing the unmodified BAC:  For the positive 
selection using galactose as the only carbon source, cells not expressing galK stop 
growing but are not killed. Therefore, when colonies are picked from the gal 
plate, small numbers of "hitch-hiker" cells might also get picked, which can 
recover later in normal media and survive the DOG selection. To eliminate the 
contamination of these "hitch-hikers", the galK-positive clone should be streaked 
onto a MacConkey indicator plates and only isolated, bright red colonies should 
be picked for subsequent removal of galK. 2) High background: Apart from the desired removal of galK, loss-of-function 
mutations of the galK gene can also give rise to clones surviving the DOG 
selection. As a control for galK removal, ddH2O is transfected into a heat-shocked 
sample to evaluate the spontaneous mutation frequency of galK.   Even with a 
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high background level, screening large numbers of colonies (15-20) by colony 
PCR should enable identification of correct galK deletions.	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Figures: 
Figure C.1. Inserting large DNA sequences into BACs using galK selection.  
 
 
 
 
(A) A linear DNA targeting construct contains three homology regions, A, B, and C:  X, 
the DNA sequence to be inserted, is placed between A and B and galK, the selectable 
marker, is placed between B and C.  In bacteria, recombination between homology boxes 
A and C results in insertion of X and galK, separated by homology region B, into the 
BAC.  (B) A DNA fragment corresponding to homology boxes B and C is used to delete 
galK by homologous recombination using negative selection against galK.   
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Figure C.2. Deleting DNA sequences within a BAC using galK selection.  
 
 
 
(A) Linear DNA targeting construct is formed by inserting galK between homology 
regions A and B which flank the region to be deleted. Recombination with the target 
BAC in bacteria results in deletion of the DNA sequence between homology regions A 
and B with insertion of galK between regions A and B.  (B) Using a DNA targeting 
construct consisting of homology regions A and B, galK can be removed by homologous 
recombination, allowing another round of deletions, if necessary. 
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APPENDIX D 
 
HSP70 BAC Transgenes Response after Heat Shock 
 
Bacterial Artificial Chromosomes or BACs are large DNA constructs carrying 
100-300 kb of mammalian genomic fragments. Previous work done in the Belmont 
laboratory strongly suggested that low copy number BAC transgene arrays more closely 
approximate the behavior of endogenous loci. To compare the results from plasmid 
transgenes used in Chapter 2, I made a stable cell line containing an estimated 1-3 copies 
of the HSP70 BAC transgene to investigate its behavior in response to heat shock. This 
BAC has two of the three HSP70 genes deleted. It also has a 24 copies of MS2 repeats 
inserted in the 3’UTR (Fig. D.1.A).  
There are several technical hurdles with this cell line. First, since BAC transgenes 
are not as bright as plasmid transgenes, it is difficult to distinguish BAC transgenes from 
nuclear speckles using the same color (Fig. D.1A). Second, in most cells, HSP70 BAC 
transgene array are localized near a preexisting nuclear speckle even before heat shock 
activation, hence it is difficult to determine how transgenes associate with speckles. 
Third, the heat shock response of HSP70 BAC transgenes occurs faster and more 
synchronously than plasmid transgenes; hence it is difficult to capture the initial few time 
points where gene/speckle and/or transcript accumulation occurs.  
However, there were few examples where the HSP70 BAC transgene can be 
clearly distinguished from the nuclear speckles and in which before heat shock the BAC 
is clearly separated away from nuclear speckle (Fig. D.1A-B). To be able to repeat these 
observations with much higher number of cells, I also generated  a stable cell line 
containing mCherry tagged lac repressor. A few examples of long-range motion of 
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HSP70 BAC transgenes towards speckle were observed (Fig. D2.B-C). Work is now in 
progress to tag the MS2 binding protein with a third color to visualize transgenes, 
transcripts and speckles, all at the same time in live-cells. Using this three-color 
approach, we will be able to clearly visualize the dynamics between the Hsp70 transgene, 
RNA transcripts from the Hsp70 transgene and nuclear speckles in live cells. 
 
  
 
 
 130 
Figures: 
 
Figure D.1. HSP70 BAC transgenes show heat shock induced speckle association 
followed by an increase in transcript signal. 
 
A 
 
 
B 
 
 
C 
 
(A) Schematic showing HSP70 BAC with 256-mer LacO repeat (red), Kan/Neo 
selectable marker (yellow), HSPA1B gene (blue), and a 24-mer MS2 repeat (magenta) 
inserted into the HSPA1B 3’UTR.  Scale bar = 10 kb. (B and C) Transcript signal 
(mCherry-MS2-binding protein, red) increases above background levels shortly after first 
contact of transgene array (bright green) with nuclear speckle (lighter green). The top 
inset shows that green channel, and the bottom inset shows the red channel. Time is 
minutes (’) after heat shock. 
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HSPA1B
C6orf48 NEU1 SLC EHMT2 ZBT12
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 131 
Figure D.2. HSP70 BAC transgenes show heat shock induced speckle association. 
 
 
 
 
(A-C) Live-cell imaging shows HSP70 BAC (red, mCherry-LacI) movement of BAC 
transgene to nearby nuclear speckle (green, EGFP-SON) (B), stretching of BAC 
transgenes followed by long-range movement to nearby nuclear speckle (C), and another 
example of long-range BAC transgene motion towards a nuclear speckle (D).  Time 
shown is minutes (‘) after HS.  Insets show 2-fold enlarged views of transgene region. 
Scale bars= 2 µm. 
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APPENDIX E 
 
Supplementary Images of Nuclear Speckles  
 
Figure E.1. Survey of different speckle markers. 
 
 
       EGFP-SC35                        mRFP-Magoh                        EGFP-SRP20           mRFP-SRSF1  
 
Several different fluorescently tagged speckle markers were tested by transiently 
transfecting in CHO cells. Magon and SON (below) had better contrast than others. 
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Figure E.2. Survey of different cell lines for speckle staining. 
 
  
 
 
  
       
 
Different cell lines were transiently transfected with YFP-SON plasmid. Scale bar 2µm. 
Among the tested cell lines, CHO cell line gave best contrast speckle staining. 
  
CHO Hela-S3 HEK293 
PC3M Melan A 
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Figure E.3. Speckle enlargement next to the HSP70 transgene. 
A 
 
 
Transient association of nuclear speckle (less bright grey signal) with the transgene 
(bright grey signal), followed by formation of a nuclear speckle near transgenes. Time in 
minutes after heat shock. 
 
B 
 
 
Formation of bigger nuclear speckle (less bright grey signal) near the HSP70 transgene 
(bright grey signal) after heat shock. Time is in minutes. 
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Figure E.4. Near straight line, long-range movement of nuclear speckles after Heat 
Shock. 
 
A 
 
 
Movement of speckles towards a distant speckle (shown will a yellow arrowhead) after 
Heat Shock.  De novo speckles appear near the HSP70 transgene and they appear to 
follow the same trajectory towards a distance speckle. This phenomenon was termed as 
“Projectile Vomit” by Dr. Andrew S. Belmont. Time is in minutes. Scale bar: 2µm. 
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Figure E.4. Cont. 
 
B 
 
 
 
Two speckles, labeled by arrowheads (yellow and white), show movement towards 
another larger speckle. Imaging was started after 2h of Cd treatment (75µM). Time is in 
seconds. Similar movement of speckles was observed after alpha-amanitin treatment (The 
work is followed up by another Graduate Student in Belmont laboratory). Time is in 
seconds. Scale bar: 2µm. 
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APPENDIX E 
Supplementary Videos 
Video E1.  Long-range movement of HSP70 plasmid transgenes after heat shock.  
Transgenes tagged with EGFP-lac repressor (bright grey signal) are visualized relative to 
nuclear speckles tagged with EGFP-SON (less bright grey signal).  Time shown is 
minutes after beginning of heat shock.  Scale bar = 2 µm.  Transgenes move across width 
of nucleus to associate with nuclear speckle.  Movie represents 2D projection of 3D 
image stack for each time point.   
 
Video E2. No nuclear rotation during long-range movement of HSP70 plasmid 
transgenes after heat shock.  Centromeres (red, mCherry-CenpA) remain relatively 
fixed during several µm movement of EGFP-lac repressor tagged HSP70 transgenes 
(bright green) to a nuclear speckle (less bright green).  Time shown is minutes after 
beginning of heat shock.  Scale bar = 2 µm.  Movie represents 2D projection of 3D image 
stack for each time point.   
 
Video E3.  Linear trajectory revealed by 30 sec time sampling.  Unidirectional, linear 
progressive motion of transgene (EGFP-lac repressor tagged, bright green) toward 
nuclear speckle (EGFP-SON, less bright green) is visualized using 30 sec time sampling.  
Centromeres (red, mCherry-CenpA) remain relatively fixed, again ruling out nuclear 
rotation during this motion.  Time shown is minutes after beginning of heat shock.  Scale 
bar = 2 µm.  Movie represents 2D projection of 3D image stack for each time point.   
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Video E4.  Chromatin stretching parallel to direction of movement.   An example of 
chromatin stretching in the direction of long-range movement.  Scale bar = 2 µm.  Movie 
represents 2D projection of 3D image stack for each time point.  Time shown is minutes 
after beginning of heat shock. 
 
Video E5.  Extensive, linear elongation/extension of transgene array chromatin 
suggests a force-driven stretching process.  Transgene array tagged by EGFP-lac 
repressor (bright green), centromeres tagged by mCherry-CenpA, nuclear speckles 
labeled by EGFP-SON (less bright green).  Scale bar = 2 µm.  Movie represents 2D 
projection of 3D image stack for each time point.  Time shown is minutes after beginning 
of heat shock. 
 
Video E6.  Transcription signal appears after nuclear speckle contact.  Appearance 
of HSP70 transcript / mCherry-MS2-binding protein signal (22 min) above background 
levels occurs just after first contact with nuclear speckle (21 min).  Time shown is 
minutes after beginning of heat shock.  HSP70 transgene array is tagged with EGFP-lac 
repressor (bright green), speckles with EGFP-SON (less bright green), and nascent 
transcript with mCherry-MS2-binding protein (red).  Scale bar = 2 µm.  Movie represents 
2D projection of 3D image stack for each time point. 
 
 
 
 
 
 
 
